Selected Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2015

Schedule of Quarterly Financial Information [Table Text Block]

					Operating			Net Income (Loss) From Continuing  Operations									Net Income (loss)
(In thousands, except per share  amounts)	Revenues		Gross Profit		Income  (Loss)			Amount			Per Basic Share			Per Diluted Share			Amount			Per Basic Share			Per Diluted Share
Year Ended December 31, 2015:
4th Quarter	$	279,977	$	174,430	$	64,475		$	32,785		$	0.27		$	0.27		$	32,785		$	0.27		$	0.27
3rd Quarter	256,801		163,012		90,767			47,967			0.40			0.39			47,967			0.40			0.39
2nd Quarter	220,920		128,407		66,102			32,508			0.28			0.27			32,508			0.28			0.27
1st Quarter	227,378		130,163		73,267			37,538			0.33			0.31			37,538			0.33			0.31
Year Ended December 31, 2014:
4th Quarter — (As restated)	$	202,856	$	105,333	$	48,670		$	17,979		$	0.17		$	0.16		$	17,979		$	0.17		$	0.16
3rd Quarter — (As restated)	127,698		45,500		(12,030		)	(12,333		)	(0.12		)	(0.12		)	(12,333		)	(0.12		)	(0.12		)
2nd Quarter — (As restated)	133,872		60,871		736			(752		)	(0.01		)	(0.01		)	(1,256		)	(0.01		)	(0.01		)
1st Quarter — (As restated)	90,622		49,656		23,440			9,494			0.10			0.08			9,494			0.10			0.08

Restatement to Prior Year Income [Table Text Block]

The effect of the restatement on the previously filed condensed consolidated balance sheet as of December 31, 2014 is as follows, in thousands:

	December 31, 2014
	As Previously  Reported			Restatement  Adjustment				As Restated
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	70,680		$	(1	)	(i)	$	70,679
Trade accounts receivable, net	220,716			(33,171		)	(a), (b), (c)	187,545
Inventories, net	131,310			3,887			(d), (f)	135,197
Deferred taxes, current	33,480			4,931			(e), (i)	38,411
Available for sale security, current	7,268			—				7,268
Prepaid expenses and other current assets	30,875			6,186			(c), (d), (e)	37,061
TOTAL CURRENT ASSETS	494,329			(18,168		)		476,161
PROPERTY, PLANT AND EQUIPMENT, NET	143,788			408			(c), (d)	144,196
OTHER LONG-TERM ASSETS
Goodwill	278,774			6,509			(e)	285,283
Product licensing rights, net	704,218			573			(e)	704,791
Other intangibles, net	259,141			(3,529		)	(e)	255,612
Deferred financing costs, net	21,560			2,144			(c), (d), (h)	23,704
Deferred taxes, non-current	3,020			(936		)	(i)	2,084
Long-term investments	208			3			(i)	211
Other non-current assets	1,863			—				1,863
TOTAL OTHER LONG-TERM ASSETS	1,268,784			4,764				1,273,548
TOTAL ASSETS	$	1,906,901		$	(12,996	)		$	1,893,905
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Trade accounts payable	$	44,116		$	3,201		(c), (d)	$	47,317
Purchase consideration payable, current	7,481			3,489			(e)	10,970
Income taxes payable	1			(1)			(i)	—
Accrued royalties	13,041			163			(d)	13,204
Accrued compensation	13,467			—				13,467
Current maturities of long-term debt	10,450			—				10,450
Accrued administrative fees	27,774			13,096			(b), (d)	40,870
Accrued expenses and other liabilities	17,835			(3,259		)	(c), (d), (e)	14,576
TOTAL CURRENT LIABILITIES	134,165			16,689				150,854
LONG-TERM LIABILITIES
Long-term debt	1,114,481			—				1,114,481
Deferred tax liability, non-current	268,968			460			(e)	269,428
Lease incentive obligations and other long-term liabilities	2,536			300			(c), (d)	2,836
TOTAL LONG-TERM LIABILITIES	1,385,985			759				1,386,745
TOTAL LIABILITIES	1,520,150			17,448				1,537,599
SHAREHOLDERS’ EQUITY
Common stock, no par value — 150,000,000 shares authorized; 111,734,901 shares issued and outstanding at December 31, 2014	351,235			(8,983		)	(i)	342,252
Warrants to acquire common stock	—			—				—
Retained earnings	50,711			(21,461		)	(a), (b), (c), (d), (e), (f)	29,250
Accumulated other comprehensive loss	(15,195		)	—				(15,195		)
TOTAL SHAREHOLDERS’ EQUITY	386,751			(30,444		)		356,307
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	1,906,901		$	(12,996	)		$	1,893,905

The effect of the restatement on the previously filed consolidated income statement for the year ended December 31, 2014 is as follows, in thousands except per share amounts:

	Year ended December 31, 2014
	As Previously  Reported			Restatement  Adjustment				As Restated
REVENUES	$	593,078		$	(38,030	)	(a), (b), (c)	$	555,048
Cost of sales (exclusive of amortization of intangibles, included within operating expenses below)	295,488			(1,800		)	(c), (d), (f)	293,688
GROSS PROFIT	297,590			(36,230		)		261,360
Selling, general and administrative expenses	95,463			(2,508		)	(c), (d)	92,955
Acquisition-related costs	32,147			693			(c), (d)	32,840
Research and development expenses	29,199			2,057			(c), (d)	31,256
Amortization of intangibles	44,066			(573		)	(e)	43,493
TOTAL OPERATING EXPENSES	200,875			(331		)		200,544
OPERATING INCOME	96,715			(35,899		)		60,816
Amortization of deferred financing costs	(12,129		)	2,144			(c), (d), (h)	(9,985		)
Interest expense, net	(35,657		)	—				(35,657		)
Gain from product divestiture	9,807			(510		)	(e)	9,297
Other non-operating income, net	400			471			(c), (d)	871
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	59,136			(33,794		)		25,342
Income tax provision	23,288			(12,334		)	(i)	10,954
INCOME FROM CONTINUING OPERATIONS	$	35,848		$	(21,460	)		$	14,388
Loss from discontinued operations, net of tax	$	(503	)	$	(1	)	(i)	$	(504	)
CONSOLIDATED NET INCOME	$	35,345		$	(21,461	)		$	13,884
CONSOLIDATED NET INCOME PER COMMON SHARE:
Income from continuing operations, basic	$	0.35		$	(0.21	)		$	0.14
Loss from discontinued operations, basic	$	(0.01	)	$	—			$	(0.01	)
CONSOLIDATED NET INCOME, BASIC	$	0.34		$	(0.21	)		$	0.13
Income from continuing operations, diluted	$	0.34		$	(0.21	)		$	0.13
Loss from discontinued operations, diluted	$	(0.01	)	$	0.01			$	—
CONSOLIDATED NET INCOME, DILUTED	$	0.33		$	(0.20	)		$	0.13
SHARES USED IN COMPUTING CONSOLIDATED NET INCOME PER COMMON SHARE:
BASIC	103,480			—				103,480
DILUTED	123,110			(13,522)				109,588
COMPREHENSIVE INCOME:
Consolidated net income	$	35,345		$	(21,461	)		$	13,884
Unrealized holding loss on available-for-sale securities, net of tax of $663	(1,124		)	—				(1,124		)
Foreign currency translation loss, net of tax of $877 for the year ended December 31, 2014	(1,704		)	—				(1,704		)
COMPREHENSIVE INCOME	$	32,517		$	(21,461	)		$	11,056

The effect of the restatement on the previously filed consolidated statement of cash flows for the year ended December 31, 2014 is as follows, in thousands:

	Year ended December 31, 2014
	As Previously  Reported			Restatement  Adjustment				As Restated
OPERATING ACTIVITIES:
Consolidated net income	$	35,345		$	(21,461	)	(a), (b), (c), (d), (e), (f)	$	13,884
Loss from discontinued operations, net of tax	503			1			(i)	504
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization	58,538			(707		)	(c), (d)	57,831
Amortization of deferred financing fees	12,129			(2,145		)	(c), (d), (h)	9,984
Amortization of favorable (unfavorable) contracts	72			(1		)	(i)	71
Amortization of inventory step-up	20,798			—				20,798
Non-cash stock compensation expense	7,542			210			(i)	7,752
Non-cash interest expense	4,871			—				4,871
Non-cash gain on bargain purchase	—			—				—
Gain from product divestiture	(9,807		)	478			(e)	(9,329		)
Deferred income taxes, net	25,293			(42,804		)	(e)	(17,511		)
Excess tax benefit from stock compensation	(38,710		)	9,193			(e)	(29,517		)
Non-cash settlement of product warranty liability	—			—				—
Equity in earnings of unconsolidated joint venture	—			—				—
Loss on extinguishment of debt	990			—				990
Gain on sale of available for sale security	(7		)	—				(7		)
Changes in operating assets and liabilities, net of business acquisitions:
Trade accounts receivable, net	(95,470		)	22,674			(a), (b), (c)	(72,796		)
Inventories, net	(15,262		)	(4,123		)	(c), (d), (f)	(19,385		)
Prepaid expenses and other current assets	(13,180		)	43,552			(c), (d)	30,372
Trade accounts payable	11,024			2,939			(c), (d)	13,963
Accrued expenses and other liabilities	26,249			1,718			(c), (d)	27,967
NET CASH PROVIDED BY OPERATING ACTIVITIES	30,918			9,254				40,442
INVESTING ACTIVITIES:
Payments for acquisitions and equity investments, net of cash acquired	(987,802		)	374			(e)	(987,428		)
Proceeds from disposal of assets	59,361			___			(e)	59,361
Payments for other intangible assets	(8,532		)	(376		)	(c), (d)	(8,908		)
Purchases of property, plant and equipment	(29,568		)	(331		)	(c), (d)	(29,899		)
Distributions from unconsolidated joint venture	—			—				—
NET CASH USED IN INVESTING ACTIVITIES	(966,541		)	(333)				(966,874		)
FINANCING ACTIVITIES:
Proceeds from issuances of debt	1,045,000			—				1,045,000
Proceeds under stock option and stock purchase plans	8,842			—				8,842
Payments of contingent acquisition liabilities	(15,000		)	—				(15,000		)
Debt financing costs	(28,366		)	1			(i)	(28,365		)
Proceeds from warrant exercises	8,171			—				8,171
Excess tax benefits from stock compensation	38,710			(9,193		)	(i)	29,517
Debt repayment	(85,049		)	—				(85,049		)
NET CASH PROVIDED BY FINANCING ACTIVITIES	972,308			(9,192		)		963,116
Effect of changes in exchange rates on cash and cash equivalents	(183		)	—				(183		)
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	36,502			(1		)		36,501
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	34,178			—				34,178
CASH AND CASH EQUIVALENTS AT END OF YEAR	$	70,680		$	(1	)		$	70,679

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The following table summarizes the basis used to measure the fair values of the Company’s financial instruments (amounts in thousands):

			Fair Value Measurements at Reporting Date,  Using:
Description	December 31, 2015		Quoted  Prices in Active Markets for Identical  Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	346,266	$	346,266	$	—	$	—
Available-for-sale securities	5,941		4,843		—		1,098
Total assets	$	352,207	$	351,109	$	—	$	1,098
Purchase consideration payable	$	4,967	$	—	$	—	$	4,967
Total liabilities	$	4,967	$	—	$	—	$	4,967

Description	December 31, 2014		Quoted  Prices in Active Markets for Identical  Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents (as Restated)	$	70,679	$	70,679	$	—	$	—
Available-for-sale securities (as Restated)	8,391		—		—		8,391
Total assets (as Restated)	$	79,070	$	70,679	$	—	$	8,391
Purchase consideration payable (as Restated)	$	11,101	$	—	$	—	$	11,101
Total liabilities (as Restated)	$	11,101	$	—	$	—	$	11,101

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	2015			2014 (as Restated)			2013
Expected volatility	42%	—	47%	40%	—	71%	49%	—	68%
Expected life (in years)		4.8			4.1			4.0
Risk-free interest rate	1.5%	—	1.6%	0.9%	—	2.2%	0.7%	—	1.4%
Dividend yield		—			—			—
Fair value per stock option		$14.59			$12.89			$6.95

Schedule of Share-based Compensation, Activity [Table Text Block]

	Number of Shares (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands) (1)
Outstanding at December 31, 2012	9,727		$	4.22
Granted	321		15.76
Exercised	(630	)	4.18
Forfeited or expired	(190	)	13.10
Outstanding at December 31, 2013	9,228		$	4.45
Granted	1,475		28.59
Exercised	(4,226	)	1.91
Forfeited or expired	(91	)	22.56
Outstanding at December 31, 2014	6,386		$	11.44
Granted	1,016		37.60
Exercised	(2,519	)	4.09
Forfeited or expired	(121	)	34.78
Outstanding at December 31, 2015	4,762		$	20.33	3.41	$	80,868
Exercisable at December 31, 2015	2,510		$	11.28	1.43	$	65,341

(1) May include value from potentially anti-dilutive options whose exercise price exceeds the closing stock price.

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

	Number of Units (in thousands)		Weighted Average Grant Date Fair Value
Nonvested at December 31, 2012	18		$	14.63
Granted	32		15.36
Vested	(34	)	14.98
Canceled	—		—
Nonvested at December 31, 2013	16		$	15.36
Granted	337		35.31
Vested	(16	)	15.36
Canceled	—		—
Nonvested at December 31, 2014	337		$	35.31
Granted	—		—
Vested (1)	(84	)	35.31
Canceled	—		—
Nonvested at December 31, 2015	253		$	35.31

(1) As a result of the delay in filing the 2015 financials, approximately 66,000 units of restricted stock vested but have not yet been issued to grantees as of and for the year ended December 31, 2015.

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]

Net trade accounts receivable consists of the following (in thousands):

	December 31,
	2015			2014 (as Restated)
Gross accounts receivable	$	466,570		$	446,925
Less reserves for:
Chargebacks and rebates	(254,440		)	(198,112		)
Product returns	(48,333		)	(44,646		)
Discounts and allowances	(10,079		)	(15,554		)
Advertising and promotions	(1,518		)	(758		)
Doubtful accounts	(1,579		)	(309		)
Trade accounts receivable, net	$	150,621		$	187,545

Schedule Of Adjustments To Gross Sales [Table Text Block]

For the years ended December 31, 2015, 2014 and 2013, the Company recorded the following adjustments to gross sales (in thousands):

	Year ended December 31,
	2015			2014 (as Restated)			2013
Gross sales	$	2,511,693		$	1,433,603		$	528,574
Less adjustments for:
Chargebacks and rebates	(1,361,030		)	(775,964		)	(183,403		)
Product returns	(34,272		)	(20,993		)	(5,001		)
Discounts and allowances	(50,385		)	(30,782		)	(8,464		)
Administrative fees	(71,727		)	(44,558		)	(9,471		)
Advertising, promotions and other	(9,203		)	(6,258		)	(4,524		)
Revenues, net	$	985,076		$	555,048		$	317,711

Schedule of Inventory, Current [Table Text Block]

The components of inventories, net of allowances, are as follows (in thousands):

	December 31,
	2015		2014 (as Restated)
Finished goods	$	76,512	$	69,499
Work in process	8,905		4,075
Raw materials and supplies	99,899		61,623
	$	185,316	$	135,197

Property, Plant and Equipment [Table Text Block]

Property, plant and equipment consist of the following (in thousands):

	December 31,
	2015			2014 (as Restated)
Land	$	17,409		$	9,323
Buildings and leasehold improvements	85,767			63,846
Furniture and equipment	142,885			112,552
	246,061			185,721
Accumulated depreciation	(87,086		)	(67,937		)
	158,975			117,784
Construction in progress	20,639			26,412
	$	179,614		$	144,196

Schedule of Goodwill [Table Text Block]

Changes in goodwill during the two years ended December 31, 2015 were as follows (in thousands):

	Goodwill
December 31, 2013	$	29,831
Acquisitions and other adjustments	271,249
Impairments	—
Dispositions	(15,284		)
Foreign currency translation	(513		)
December 31, 2014	$	285,283
Acquisitions and other adjustments	—
Impairments	—
Dispositions	—
Foreign currency translation	(573		)
December 31, 2015	$	284,710

Schedule of Finite-Lived Intangible Assets [Table Text Block]

The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of December 31, 2015 for those assets that are not already fully amortized (dollar amounts in thousands):

	Gross Carrying Amount		Accumulated Amortization			Reclassifications (1)			Impairment (2)			Net Carrying Amount		Weighted Average Remaining Amortization Period (years)
Product licensing rights	$	782,269	$	(132,642	)	$	38,000		$	(34,000	)	$	653,627	13.2
IPR&D	227,559		—			(38,000		)	(2,627		)	186,932		N/A – Indefinite lived
Trademarks	16,000		(2,982		)	—			—			13,018		21.8
Customer relationships	6,493		(3,716		)	—			—			2,777		11.7
Other intangibles	11,235		(2,600		)	—			—			8,635		7.9
Non-compete agreements	2,167		(2,167		)	—			—			—		0.0
	$	1,045,723	$	(144,107	)	$	—		$	(36,627	)	$	864,989

(1) This amount reclassifies the acquisition date value of one previously IPR&D asset due to launch in the year ended December 31, 2015.

(2) Impairment of product licensing rights is stated at gross carrying cost of $34.0 million less accumulated amortization of $3.6 million as of the impairment date. Accordingly, the net impairment expense recognized in product licensing rights was $30.4 million as of and for the year ended December 31, 2015.

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

A reconciliation of the earnings per share data from a basic to a fully diluted basis is detailed below (amounts in thousands, except per share data):

	2015		(3) 2014 (as Restated)			2013
Income from continuing operations used for basic earnings per share	$	150,798	$	14,388		$	52,362
Convertible debt income adjustments, net of tax	3,222		—			—
Income from continuing operations adjusted for convertible debt as used for diluted earnings per share	$	154,020	$	14,388		$	52,362
Income from continuing operations per share:
Basic	$	1.29	$	0.14		$	0.54
Diluted (1)	$	1.22	$	0.13		$	0.46
Loss from discontinued operations, net of tax	$	—	$	(504	)	$	—
Loss from discontinued operations, net of tax per share:
Basic	$	—	$	(0.01	)	$	—
Diluted	$	—	$	—		$	—
Shares used in computing income (loss) per share:
Weighted average basic shares outstanding	116,980		103,480			96,181
Dilutive securities:
Stock options and unvested RSUs	1,667		4,234			4,516
Stock warrants	—		1,874			6,702
Shares issuable on conversion of the Notes (2)	7,115		—			6,499
Total dilutive securities	8,782		6,108			17,717
Weighted average diluted shares outstanding	125,762		109,588			113,898

(1) Due to a change in the expectation that management may settle all future note conversions solely through shares in the year and quarter ended December 31, 2014, the diluted income from continuing operations per share calculation includes the dilutive effect of convertible debt and is offset by the exclusion of interest expense and deferred financing fees related to the convertible debt of $3.2 million, after-tax for the year ended December 31, 2015.

(2) Shares issuable on conversion of the Notes for the year ended December 31, 2015 have increased in comparison to the fiscal year ended December 31, 2013 due to stock appreciation which underlies the shares issuable on conversion of the Notes and the Company’s change in practice on October 1, 2014 to more likely than not settle future Note conversions solely through shares as we are now utilizing the if-converted method for convertible debt conversion obligations. This practice was continued in the year ended December 31, 2015.

(3) In the year ended December 31, 2014 the computation of diluted net earnings per share does not include the effect of convertible debt under the if-converted method, consisting of 13.5 million shares and $5.8 million of additional income, as the effect would have been antidilutive.

Schedules of Concentration of Risk, by Risk Factor [Table Text Block]

	2015						2014 (as Restated)						2013
	Gross Sales		Net Revenue		Gross Accounts Receivable		Gross Sales		Net Revenue		Gross Accounts Receivable		Gross Sales		Net Revenue		Gross Accounts Receivable
Amerisource	28.0	%	23.2	%	28.8	%	38.3	%	29.2	%	45.4	%	18.9	%	14.0	%	25.5	%
Cardinal	19.7	%	19.5	%	26.1	%	15.9	%	13.6	%	16.9	%	22.8	%	15.6	%	26.2	%
McKesson	30.1	%	27.3	%	27.9	%	22.7	%	19.1	%	22.7	%	16.7	%	11.3	%	11.6	%
Total	77.8	%	70.0	%	82.8	%	76.9	%	61.9	%	85.0	%	58.4	%	40.9	%	63.3	%

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

The income tax provision (benefit) from continuing operations consisted of the following (in thousands):

	Current		Deferred			Total
Year ended December 31, 2015
Federal	$	116,375	$	(41,477	)	$	74,898
State	11,113		(2,620		)	8,493
Foreign	—		(2,033		)	(2,033		)
	$	127,488	$	(46,130	)	$	81,358
Year ended December 31, 2014 (as Restated)
Federal	$	26,114	$	(14,222	)	$	11,892
State	2,347		(2,090		)	257
Foreign	4		(1,199		)	(1,195		)
	$	28,465	$	(17,511	)	$	10,954
Year ended December 31, 2013
Federal	$	27,985	$	(3,050	)	$	24,935
State	4,145		2,051			6,196
Foreign	—		(598		)	(598		)
	$	32,130	$	(1,597	)	$	30,533

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Selected financial information by reporting segment is presented below (in thousands)

	Years ended December 31,
	2015		2014 (as Restated)		2013
REVENUES
Prescription Pharmaceuticals	$	924,472	$	504,688	$	279,911
Consumer Health	60,604		50,360		37,800
Total revenues	$	985,076	$	555,048	$	317,711
GROSS PROFIT
Prescription Pharmaceuticals	$	566,298	$	233,833	$	151,182
Consumer Health	29,714		27,527		20,722
Total gross profit	$	596,012	$	261,360	$	171,904

Interim Financial Information [Member]

Restatement to Prior Year Income [Table Text Block]

The effect of the restatement on the previously filed consolidated income statement for the quarter ended December 31, 2014 is as follows, in thousands except per share amounts:

	Quarter ended December 31, 2014
	As Previously  Reported			Restatement  Adjustment				As Restated
REVENUES	$	227,828		$	(24,972	)	(a), (b), (c)	$	202,856
Cost of sales (exclusive of amortization of intangibles, included within operating expenses below)	99,446			(1,923		)	(c), (d), (f)	97,523
GROSS PROFIT	128,382			(23,049		)		105,333
Selling, general and administrative expenses	29,122			(720		)	(c), (d)	28,402
Acquisition-related costs	2,858			429			(c), (d)	3,287
Research and development expenses	7,810			681			(c), (d)	8,491
Amortization of intangibles	16,685			(202		)	(e)	16,483
TOTAL OPERATING EXPENSES	56,475			188				56,663
OPERATING INCOME	71,907			(23,237		)		48,670
Amortization of deferred financing costs	(1,030		)	(86		)	(h)	(1,116		)
Interest expense, net	(13,773		)	(4		)	(c), (d)	(13,777		)
Gain (loss) from product divestiture	—			(40		)		(40		)
Other non-operating income (loss), net	(580		)	88			(c), (d)	(492		)
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	56,524			(23,279		)		33,245
Income tax provision	22,292			(7,026		)	(i)	15,266
INCOME FROM CONTINUING OPERATIONS	$	34,232		$	(16,253	)		$	17,979
Loss from discontinued operations, net of tax	—			—				—
CONSOLIDATED NET INCOME	$	34,232		$	(16,253	)		$	17,979
CONSOLIDATED NET INCOME PER COMMON SHARE:
Income from continuing operations, basic	$	0.32		$	(0.15	)		$	0.17
Loss from discontinued operations, basic	—			—				—
CONSOLIDATED NET INCOME, BASIC	$	0.32		$	(0.15	)		$	0.17
Income from continuing operations, diluted	$	0.29		$	(0.13	)		$	0.16
Loss from discontinued operations, diluted	—			—				—
CONSOLIDATED NET INCOME, DILUTED	$	0.29		$	(0.13	)		$	0.16
SHARES USED IN COMPUTING CONSOLIDATED NET INCOME PER COMMON SHARE:
BASIC	108,515			—				108,515
DILUTED	124,491			—				124,491
COMPREHENSIVE INCOME:
Consolidated net income	$	34,232		$	(16,253	)		$	17,979
Unrealized holding loss on available-for-sale securities, net of tax of $1,294	(2,194		)	1			(i)	(2,193		)
Foreign currency translation loss, net of tax of $922 for the quarter ended December 31, 2014	(1,790		)	—				(1,790		)
COMPREHENSIVE INCOME	$	30,248		$	(16,252	)		$	13,996

The effect of the restatement on the previously filed condensed consolidated balance sheet as of the quarter ended September 30, 2014 is as follows, in thousands:

	September 30, 2014
	As Previously Restated			Restatement  Adjustment				As Restated
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	131,466		$	—			$	131,466
Trade accounts receivable, net	145,212			(17,240		)	(a), (b), (c)	127,972
Inventories, net	132,830			(714		)	(c), (d), (f)	132,116
Deferred taxes, current	40,708			23,268			(e)	63,976
Available for sale security, current	10,804			—				10,804
Prepaid expenses and other current assets	33,075			(5,743		)	(c), (d)	27,332
TOTAL CURRENT ASSETS	494,095			(429		)		493,666
PROPERTY, PLANT AND EQUIPMENT, NET	139,372			2			(c)	139,374
OTHER LONG-TERM ASSETS
Goodwill	285,080			801			(e)	285,881
Product licensing rights, net	670,757			370			(e)	671,127
Other intangibles, net	254,685			(3,529		)	(e)	251,156
Deferred financing costs, net	22,942			2,230			(c), (d), (h)	25,172
Deferred taxes, non-current	1,746			—				1,746
Long-term investments	208			3			(i)	211
Other non-current assets	2,377			—				2,377
TOTAL OTHER LONG-TERM ASSETS	1,237,795			(125		)		1,237,670
TOTAL ASSETS	$	1,871,262		$	(552	)		$	1,870,710
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Trade accounts payable	$	36,714		$	1,491		(c), (d)	$	38,205
Purchase consideration payable, current	20,728			3,488			(c), (d), (e)	24,216
Income taxes payable	—			—				—
Accrued royalties	14,533			—				14,533
Accrued compensation	12,625			352			(c), (d)	12,977
Current maturities of long-term debt	10,494			—				10,494
Accrued administrative fees	3,105			5,793			(c), (d)	8,898
Accrued expenses and other liabilities	35,616			(3,659		)	(c), (d)	31,957
TOTAL CURRENT LIABILITIES	133,815			7,465				141,280
LONG-TERM LIABILITIES
Long-term debt	1,146,585			—				1,146,585
Deferred tax liability, non-current	274,165			(3,390		)	(e)	270,775
Lease incentive obligations and other long-term liabilities	1,946			733			(c), (d)	2,679
TOTAL LONG-TERM LIABILITIES	1,422,696			(2,657		)		1,420,039
TOTAL LIABILITIES	1,556,511			4,808				1,561,319
SHAREHOLDERS’ EQUITY
Common stock, no par value — 150,000,000 shares authorized; 107,330,516 shares issued and outstanding at September 30, 2014	309,482			(151		)	(i)	309,331
Warrants to acquire common stock	—			—				—
Retained earnings	16,480			(5,209		)	(a), (b), (c), (d), (e), (f)	11,271
Accumulated other comprehensive loss	(11,211		)	—				(11,211		)
TOTAL SHAREHOLDERS’ EQUITY	314,751			(5,360		)		309,391
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	1,871,262		$	(552	)		$	1,870,710

The effect of the restatement on the previously filed consolidated income statement for the quarter ended September 30, 2014 is as follows, in thousands except per share amounts:

	Quarter ended September 30, 2014
	As Previously Reported			Restatement Adjustment				As Restated
REVENUES	$	132,732		$	(5,034	)	(a), (b), (c)	$	127,698
Cost of sales (exclusive of amortization of intangibles, included within operating expenses below)	80,998			1,200			(c), (d), (f)	82,198
GROSS PROFIT	51,734			(6,234		)		45,500
Selling, general and administrative expenses	27,779			(980		)	(c), (d)	26,799
Acquisition-related costs	8,062			97			(c), (d)	8,159
Research and development expenses	7,918			840			(c), (d)	8,758
Amortization of intangibles	14,017			(203		)	(e)	13,814
TOTAL OPERATING EXPENSES	57,776			(246		)		57,530
OPERATING INCOME (LOSS)	(6,042		)	(5,988		)		(12,030		)
Amortization of deferred financing costs	(2,509		)	237			(c), (d), (h)	(2,272		)
Interest expense, net	(11,806		)	2			(c), (d)	(11,804		)
Gain from product divestiture	839			8			(e)	847
Other non-operating income, net	979			33			(c), (d)	1,012
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(18,539		)	(5,708		)		(24,247		)
Income tax provision (benefit)	(6,889		)	(5,025		)	(i)	(11,914		)
INCOME (LOSS) FROM CONTINUING OPERATIONS	$	(11,650	)	$	(683	)		$	(12,333	)
Loss from discontinued operations, net of tax	—			—				—
CONSOLIDATED NET INCOME (LOSS)	$	(11,650	)	$	(683	)		$	(12,333	)
CONSOLIDATED NET INCOME (LOSS) PER COMMON SHARE:
Income (loss) from continuing operations, basic	$	(0.11	)	$	(0.01	)		$	(0.12	)
Loss from discontinued operations, basic	—			—				—
CONSOLIDATED NET INCOME (LOSS), BASIC	$	(0.11	)	$	(0.01	)		$	(0.12	)
Income (loss) from continuing operations, diluted	$	(0.11	)	$	(0.01	)		$	(0.12	)
Loss from discontinued operations, diluted	—			—				—
CONSOLIDATED NET INCOME (LOSS), DILUTED	$	(0.11	)	$	(0.01	)		$	(0.12	)
SHARES USED IN COMPUTING CONSOLIDATED NET INCOME (LOSS) PER COMMON SHARE:
BASIC	105,438			—				105,438
DILUTED	105,438			—				105,438
COMPREHENSIVE INCOME (LOSS):
Consolidated net income (loss)	$	(11,650	)	$	(683	)		$	(12,333	)
Unrealized holding loss on available-for-sale securities, net of tax of ($631) for the quarter ended September 30, 2014	1,070			—				1,070
Foreign currency translation loss, net of tax of $755 for the quarter ended September 30, 2014	(1,466		)	—				(1,466		)
COMPREHENSIVE INCOME (LOSS)	$	(12,046	)	$	(683	)		$	(12,729	)

The effect of the restatement on the previously filed consolidated income statement for the year to date period ended September 30, 2014 is as follows, in thousands except per share amounts:

	Year to date period ended September 30, 2014
	As Previously Restated			Restatement Adjustment				As Restated
REVENUES	$	365,250		$	(13,058	)	(a), (b), (c)	$	352,192
Cost of sales (exclusive of amortization of intangibles, included within operating expenses below)	196,042			123			(c), (d), (f)	196,165
GROSS PROFIT	169,208			(13,181		)		156,027
Selling, general and administrative expenses	66,341			(1,788		)	(c), (d)	64,553
Acquisition-related costs	29,289			264			(c), (d)	29,553
Research and development expenses	21,389			1,376			(c, d)	22,765
Amortization of intangibles	27,381			(371		)	(e)	27,010
TOTAL OPERATING EXPENSES	144,400			(519		)		143,881
OPERATING INCOME	24,808			(12,662		)		12,146
Amortization of deferred financing costs	(11,099		)	2,230			(c), (d), (h)	(8,869		)
Interest expense, net	(21,884		)	4			(c), (d)	(21,880		)
Gain from product divestiture	9,807			(470		)	(e)	9,337
Other non-operating income, net	980			383			(c), (d)	1,363
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	2,612			(10,515		)		(7,903		)
Income tax provision (benefit)	996			(5,308		)	(i)	(4,312		)
INCOME (LOSS) FROM CONTINUING OPERATIONS	$	1,616		$	(5,207	)		$	(3,591	)
Loss from discontinued operations, net of tax	(503		)	(1		)	(i)	(504		)
CONSOLIDATED NET INCOME (LOSS)	$	1,113		$	(5,208	)		$	(4,095	)
CONSOLIDATED NET INCOME (LOSS) PER COMMON SHARE:
Income (loss) from continuing operations, basic	$	0.02		$	(0.06	)		$	(0.04	)
Loss from discontinued operations, basic	(0.01		)	0.01				—
CONSOLIDATED NET INCOME (LOSS), BASIC	$	0.01		$	(0.05	)		$	(0.04	)
Income (loss) from continuing operations, diluted	$	0.01		$	(0.05	)		$	(0.04	)
Loss from discontinued operations, diluted	—			—				—
CONSOLIDATED NET INCOME (LOSS), DILUTED	$	0.01		$	(0.05	)		$	(0.04	)
SHARES USED IN COMPUTING CONSOLIDATED NET INCOME (LOSS) PER COMMON SHARE:
BASIC	101,784			—				101,784
DILUTED	118,535			(16,751		)		101,784
COMPREHENSIVE INCOME (LOSS):
Consolidated net income (loss)	$	1,113		$	(5,208	)		$	(4,095	)
Unrealized holding loss on available-for-sale securities, net of tax of ($631) for the year to date period ended September 30, 2014	1,070			—				1,070
Foreign currency translation loss, net of tax of ($44) for the year to date period ended September 30, 2014	86			—				86
COMPREHENSIVE INCOME (LOSS)	$	2,269		$	(5,208	)		$	(2,939	)

The effect of the restatement on the previously filed consolidated statement of cash flows for the year to date period ended September 30, 2014 is as follows, in thousands:

	Year to date period ended September 30, 2014
	As Previously Restated			Restatement Adjustment				As Restated
OPERATING ACTIVITIES:
Consolidated net income (loss)	$	1,113		$	(5,208	)	(a), (b), (c), (d), (e), (f)	$	(4,095	)
Loss from discontinued operations, net of tax	503			1				504
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization	37,773			(503		)	(c), (d)	37,270
Amortization of deferred financing fees	11,099			(2,229		)	(c), (d), (h)	8,870
Amortization of favorable (unfavorable) contracts	53			—				53
Amortization of inventory step-up	9,844			—				9,844
Non-cash stock compensation expense	4,994			71			(i)	5,065
Non-cash interest expense	3,954			1			(i)	3,955
Non-cash gain on bargain purchase	—			—				—
Gain from product divestiture	(9,807		)	478			(e)	(9,329		)
Deferred income taxes, net	9,002			(49,272		)	(e), (i)	(40,270		)
Excess tax benefit from stock compensation	(32,268		)	221			(e)	(32,047		)
Loss on extinguishment of debt	—			—				—
Gain on sale of available for sale security	—			—				—
Changes in operating assets and liabilities, net of business acquisitions:
Trade accounts receivable, net	(15,340		)	5,519			(a), (b), (c), (d)	(9,821		)
Inventories, net	(14,177		)	140			(c), (d), (f)	(14,037		)
Prepaid expenses and other current assets	(14,491		)	55,569			(c), (d)	41,078
Trade accounts payable	2,340			(452		)	(c), (d)	1,888
Accrued expenses and other liabilities	19,677			(5,248		)	(c), (d), (i)	14,429
NET CASH PROVIDED BY OPERATING ACTIVITIES	14,269			(912		)		13,357
INVESTING ACTIVITIES:
Payments for acquisitions and equity investments, net of cash acquired	(929,771		)	(1		)	(i)	(929,772		)
Proceeds from disposal of assets	58,750			—				58,750
Payments for other intangible assets	(8,499		)	1			(i)	(8,498		)
Purchases of property, plant and equipment	(19,393		)	1,615			(c), (d)	(17,778		)
Distributions from unconsolidated joint venture	—			—				—
NET CASH USED IN INVESTING ACTIVITIES	(898,913		)	1,615				(897,298		)
FINANCING ACTIVITIES:
Proceeds from issuances of debt	1,045,000			44			(i)	1,045,044
Proceeds under stock option and stock purchase plans	6,867			—				6,867
Payments of contingent acquisition liabilities	—			—				—
Debt financing costs	(28,462		)	97			(i)	(28,365		)
Proceeds from warrant exercises	8,171			—				8,171
Excess tax benefits from stock compensation	32,268			(221		)	(i)	32,047
Debt repayment	(81,813		)	(623		)	(e)	(82,436		)
NET CASH PROVIDED BY FINANCING ACTIVITIES	982,032			(704		)		981,328
Effect of changes in exchange rates on cash and cash equivalents	(99		)	—				(99		)
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	97,288			—				97,288
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	34,178			—				34,178
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	131,466		$	—			$	131,466
SUPPLEMENTAL DISCLOSURES:
Amount paid for interest	$	8,944		$	—			$	8,944
Amount paid for income taxes, net of refunds received	$	6,226		$	—			$	6,226

The effect of the restatement on the previously filed condensed consolidated balance sheet as of the quarter ended June 30, 2014 is as follows, in thousands:

	June 30, 2014
	As Previously Restated			Restatement Adjustment				As Restated
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	107,907		$	9		(i)	$	107,916
Trade accounts receivable, net	139,973			(11,199		)	(a), (b), (c), (e)	128,774
Inventories, net	108,914			4,752			(c), (d), (f)	113,666
Deferred taxes, current	23,266			16,627			(e)	39,893
Available for sale security, current	—			—				—
Prepaid expenses and other current assets	17,013			(4,736		)	(c), (d)	12,277
TOTAL CURRENT ASSETS	397,073			5,453				402,526
PROPERTY, PLANT AND EQUIPMENT, NET	135,695			(231		)	(c), (d)	135,464
OTHER LONG-TERM ASSETS
Goodwill	190,448			(4,083		)	(e)	186,365
Product licensing rights, net	429,621			167			(e)	429,788
Other intangibles, net	34,803			—				34,803
Deferred financing costs, net	16,463			2,203			(c), (d), (h)	18,666
Deferred taxes, non-current	2,451			—				2,451
Long-term investments	10,965			6			(c), (d)	10,971
Other non-current assets	579			—				579
TOTAL OTHER LONG-TERM ASSETS	685,330			(1,707		)		683,623
TOTAL ASSETS	$	1,218,098		$	3,515			$	1,221,613
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Trade accounts payable	$	37,794		$	5,660		(c), (d)	$	43,454
Purchase consideration payable, current	20,514			3,489			(c), (d)	24,003
Income taxes payable	571			(571		)	(a), (b), (c), (d), (e), (f)	—
Accrued royalties	7,071			1			(c), (d)	7,072
Accrued compensation	11,058			—				11,058
Current maturities of long-term debt	4,500			—				4,500
Accrued administrative fees	2,110			2,365			(c), (d)	4,475
Accrued expenses and other liabilities	20,055			(1,226		)	(c), (d)	18,829
TOTAL CURRENT LIABILITIES	103,673			9,718				113,391
LONG-TERM LIABILITIES
Long-term debt	706,420			—				706,420
Deferred tax liability, non-current	117,277			(1,849		)	(c), (d)	115,428
Lease incentive obligations and other long-term liabilities	1,830			335			(c), (d)	2,165
TOTAL LONG-TERM LIABILITIES	825,527			(1,514		)		824,013
TOTAL LIABILITIES	929,200			8,204				937,404
SHAREHOLDERS’ EQUITY
Common stock, no par value — 150,000,000 shares authorized; 104,088,199 shares issued and outstanding at June 30, 2014	271,584			(164		)	(i)	271,420
Warrants to acquire common stock	—			—				—
Retained earnings	28,129			(4,525		)	(a), (b), (c), (d), (e), (f)	23,604
Accumulated other comprehensive loss	(10,815		)	—				(10,815		)
TOTAL SHAREHOLDERS’ EQUITY	288,898			(4,689		)		284,209
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	1,218,098		$	3,515			$	1,221,613

The effect of the restatement on the previously filed consolidated income statement for the quarter ended June 30, 2014 is as follows, in thousands except per share amounts:

	Quarter ended June 30, 2014
	As Previously Restated			Restatement Adjustment				As Restated
REVENUES	$	141,896		$	(8,024	)	(a), (b), (c)	$	133,872
Cost of sales (exclusive of amortization of intangibles, included within operating expenses below)	74,078			(1,078		)	(c), (d), (f)	73,000
GROSS PROFIT	67,818			(6,947		)		60,871
Selling, general and administrative expenses	21,976			(808		)	(c), (d)	21,168
Acquisition-related costs	20,773			167			(c, d)	20,940
Research and development expenses	9,052			536			(c, d)	9,588
Amortization of intangibles	8,607			(168		)	(e)	8,439
TOTAL OPERATING EXPENSES	60,408			(273		)		60,135
OPERATING INCOME	7,410			(6,674		)		736
Amortization of deferred financing costs	(2,436		)	90			(c), (d)	(2,346		)
Interest expense, net	(7,917		)	—			(c), (d)	(7,917		)
Gain from product divestiture	8,968			(478		)	(e)	8,490
Other non-operating income, net	(566		)	352			(c), (d)	(214		)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	5,459			(6,710		)		(1,251		)
Income tax provision (benefit)	2,021			(2,520		)	(i)	(499		)
INCOME (LOSS) FROM CONTINUING OPERATIONS	$	3,438		$	(4,190	)		$	(752	)
Loss from discontinued operations, net of tax	(503		)	(1		)	(e)	(504		)
CONSOLIDATED NET INCOME (LOSS)	$	2,935		$	(4,191	)		$	(1,256	)
CONSOLIDATED NET INCOME (LOSS) PER COMMON SHARE:
Income (loss) from continuing operations, basic	$	0.03		$	(0.04	)		$	(0.01	)
Loss from discontinued operations, basic	—			—				—
CONSOLIDATED NET INCOME (loss), BASIC	$	0.03		$	(0.04	)		$	(0.01	)
Income (loss) from continuing operations, diluted	$	0.03		$	(0.04	)		$	(0.01	)
Loss from discontinued operations, diluted	(0.01		)	0.01				—
CONSOLIDATED NET INCOME (LOSS), DILUTED	$	0.02		$	(0.03	)		$	(0.01	)
SHARES USED IN COMPUTING CONSOLIDATED NET INCOME (LOSS) PER COMMON SHARE:
BASIC	103,183			—				103,183
DILUTED	118,092			(14,909		)		103,183
COMPREHENSIVE INCOME (LOSS):
Consolidated net income (loss)	$	2,935		$	(4,191	)		$	(1,256	)
Foreign currency translation loss, net of tax of $78 for the quarter ended June 30, 2014	(153		)	—				(153		)
COMPREHENSIVE INCOME (LOSS)	$	2,782		$	(4,191	)		$	(1,409	)

The effect of the restatement on the previously filed consolidated income statement for the year to date period ended June 30, 2014 is as follows, in thousands except per share amounts:

	Year to date period ended June 30, 2014
	As Previously Restated			Restatement Adjustment				As Restated
REVENUES	$	232,518		$	(8,024	)	(a), (b), (c)	$	224,494
Cost of sales (exclusive of amortization of intangibles, included within operating expenses below)	115,044			(1,077		)	(c), (d), (f)	113,967
GROSS PROFIT	117,474			(6,947		)		110,527
Selling, general and administrative expenses	38,562			(808		)	(c), (d)	37,754
Acquisition-related costs	21,227			167			(c), (d)	21,394
Research and development expenses	13,471			536			(c), (d)	14,007
Amortization of intangibles	13,364			(168		)	(e)	13,196
TOTAL OPERATING EXPENSES	86,624			(273		)		86,351
OPERATING INCOME	30,850			(6,674		)		24,176
Amortization of deferred financing costs	(8,590		)	1,993			(c), (d), (h)	(6,597		)
Interest expense, net	(10,078		)	2			(c), (d)	(10,076		)
Gain from product divestiture	8,968			(478		)	(e)	8,490
Other non-operating income, net	1			350			(c), (d)	351
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	21,151			(4,807		)		16,344
Income tax provision	7,885			(283		)	(i)	7,602
INCOME FROM CONTINUING OPERATIONS	$	13,266		$	(4,524	)		$	8,742
Loss from discontinued operations, net of tax	(503		)	(1		)	(e)	(504		)
CONSOLIDATED NET INCOME	$	12,763		$	(4,525	)		$	8,238
CONSOLIDATED NET INCOME PER COMMON SHARE:
Income from continuing operations, basic	$	0.13		$	(0.04	)		$	0.09
Loss from discontinued operations, basic	—			$	(0.01	)		$	(0.01	)
CONSOLIDATED NET INCOME, BASIC	$	0.13		$	(0.05	)		$	0.08
Income from continuing operations, diluted	$	0.11		$	(0.04	)		$	0.07
Loss from discontinued operations, diluted	—			—				—
CONSOLIDATED NET INCOME, DILUTED	$	0.11		$	(0.04	)		$	0.07
SHARES USED IN COMPUTING CONSOLIDATED NET INCOME PER COMMON SHARE:
BASIC	99,926			—				99,926
DILUTED	117,576			—				117,576
COMPREHENSIVE INCOME:
Consolidated net income	$	12,763		$	(4,525	)		$	8,238
Foreign currency translation loss, net of tax of ($799) for the year to date period ended June 30, 2014	1,552			—				1,552
COMPREHENSIVE INCOME	$	14,315		$	(4,525	)		$	9,790

The effect of the restatement on the previously filed consolidated statement of cash flows for the year to date period ended June 30, 2014 is as follows, in thousands:

	Year to date period ended June 30, 2014
	As Previously Restated			Restatement Adjustment				As Restated
OPERATING ACTIVITIES:
Consolidated net income	$	12,763		$	(4,525	)	(a), (b), (c), (d), (e), (f)	$	8,238
Loss from discontinued operations, net of tax	503			1			(e)	504
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization	18,865			(300		)		18,565
Amortization of deferred financing fees	8,589			(1,990		)	(c), (d), (h)	6,599
Amortization of favorable (unfavorable) contracts	35			—				35
Amortization of inventory step-up	3,559			—				3,559
Non-cash stock compensation expense	3,331			(56		)	(i)	3,275
Non-cash interest expense	2,655			—				2,655
Non-cash gain on bargain purchase	—			—				—
Gain from product divestiture	(8,968		)	(361		)	(e)	(9,329		)
Deferred income taxes, net	(9,959		)	(10,144		)	(e), (i)	(20,103		)
Excess tax benefit from stock compensation	(831		)	109				(722		)
Loss on extinguishment of debt	—			—				—
Gain on sale of available for sale security	—			—				—
Changes in operating assets and liabilities, net of business acquisitions:
Trade accounts receivable, net	(19,138		)	5,422			(a), (b), (c), (d)	(13,716		)
Inventories, net	(4,213		)	(6,014		)	(c), (d), (f)	(10,227		)
Prepaid expenses and other current assets	1,151			54,485			(c), (d)	55,636
Trade accounts payable	4,965			6,559			(c), (d)	11,524
Accrued expenses and other liabilities	8,695			(43,935		)	(c), (d), (i)	(35,240		)
NET CASH PROVIDED BY OPERATING ACTIVITIES	22,002			(749		)		21,253
INVESTING ACTIVITIES:
Payments for acquisitions and equity investments, net of cash acquired	(579,315		)	—				(579,315		)
Proceeds from disposal of assets	57,750			971			(i)	58,721
Payments for other intangible assets	(6,300		)	—				(6,300		)
Purchases of property, plant and equipment	(11,929		)	17			(d)	(11,912		)
Distributions from unconsolidated joint venture	—			—				—
NET CASH USED IN INVESTING ACTIVITIES	(539,794		)	988				(538,806		)
FINANCING ACTIVITIES:
Proceeds from issuances of debt	600,000			—				600,000
Proceeds under stock option and stock purchase plans	2,071			—				2,071
Payments of contingent acquisition liabilities	—			—				—
Debt financing costs	(19,654		)	(121		)	(i)	(19,775		)
Proceeds from warrant exercises	8,171			—				8,171
Excess tax benefits from stock compensation	831			(109		)	(i)	722
Debt repayment	—			—				—
NET CASH PROVIDED BY FINANCING ACTIVITIES	591,419			(230		)		591,189
Effect of changes in exchange rates on cash and cash equivalents	102			—				102
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	73,729			9				73,738
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	34,178			—				34,178
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	107,907		$	9			$	107,916
SUPPLEMENTAL DISCLOSURES:
Amount paid for interest	$	2,105		$	—			$	2,105
Amount paid for income taxes, net of refunds received	$	16,449		$	—			$	16,449

The effect of the restatement on the previously filed condensed consolidated balance sheet as of the quarter ended March 31, 2014 is as follows, in thousands:

	March 31, 2014
	As Previously Restated			Restatement Adjustment				As Restated
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	45,606		$	—			$	45,606
Trade accounts receivable, net	65,500			—				65,500
Inventories, net	62,013			—				62,013
Deferred taxes, current	8,038			—				8,038
Available for sale security, current	—			—				—
Prepaid expenses and other current assets	4,559			—				4,559
TOTAL CURRENT ASSETS	185,716			—				185,716
PROPERTY, PLANT AND EQUIPMENT, NET	87,675			—				87,675
OTHER LONG-TERM ASSETS
Goodwill	30,437			—				30,437
Product licensing rights, net	122,933			—				122,933
Other intangibles, net	14,283			—				14,283
Deferred financing costs, net	3,570			1,903			(h)	5,473
Deferred taxes, non-current	3,330			—				3,330
Long-term investments	10,012			—				10,012
Other non-current assets	3,556			—				3,556
TOTAL OTHER LONG-TERM ASSETS	188,121			1,903				190,024
TOTAL ASSETS	$	461,512		$	1,903			$	463,415463,415
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Trade accounts payable	$	30,632		$	—			$	30,632
Purchase consideration payable, current	18,898			—				18,898
Income taxes payable	6,559			2,180			(i)	8,739
Accrued royalties	6,480			—				6,480
Accrued compensation	4,453			—				4,453
Current maturities of long-term debt	—			—				—
Accrued administrative fees	2,110			—				2,110
Accrued expenses and other liabilities	6,929			—				6,929
TOTAL CURRENT LIABILITIES	76,061			2,180				78,241
LONG-TERM LIABILITIES
Long-term debt	109,825			—				109,825
Deferred tax liability, non-current	—			—				—
Lease incentive obligations and other long-term liabilities	1,577			57			(i)	1,634
TOTAL LONG-TERM LIABILITIES	111,402			57				111,459
TOTAL LIABILITIES	187,463			2,237				189,700
SHAREHOLDERS’ EQUITY
Common stock, no par value — 150,000,000 shares authorized; 96,697,545 shares issued and outstanding at March 31, 2014	241,571			—				241,571
Warrants to acquire common stock	17,946			—				17,946
Retained earnings	25,194			(334		)	(i)	24,860
Accumulated other comprehensive loss	(10,662		)	—				(10,662		)
TOTAL SHAREHOLDERS’ EQUITY	274,049			(334		)		273,715
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	461,512		$	1,903			$	463,415

The effect of the restatement on the previously filed consolidated income statement for the quarter ended March 31, 2014 is as follows, in thousands except per share amounts:

	Quarter ended March 31, 2014
	As Previously Restated			Restatement Adjustment				As Restated
REVENUES	$	90,622		$	—			$	90,622
Cost of sales (exclusive of amortization of intangibles, included within operating expenses below)	40,966			—				40,966
GROSS PROFIT	49,656			—				49,656
Selling, general and administrative expenses	16,586			—				16,586
Acquisition-related costs	454			—				454
Research and development expenses	4,419			—				4,419
Amortization of intangibles	4,757			—				4,757
TOTAL OPERATING EXPENSES	26,216			—				26,216
OPERATING INCOME	23,440			—				23,440
Amortization of deferred financing costs	(6,154		)	1,903			(h)	(4,251		)
Interest expense, net	(2,161		)	—				(2,161		)
Gain from product divestiture	—			—				—
Other non-operating income, net	567			—				567
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	15,692			1,903				17,595
Income tax provision (benefit)	5,864			2,237				8,101
INCOME (LOSS) FROM CONTINUING OPERATIONS	$	9,828		$	(334	)		$	9,494
Loss from discontinued operations, net of tax	—			—				—
CONSOLIDATED NET INCOME (LOSS)	$	9,828		$	(334	)		$	9,494
CONSOLIDATED NET INCOME (LOSS) PER COMMON SHARE:
Income (loss) from continuing operations, basic	$	0.10		$	—			$	0.10
Loss from discontinued operations, basic	—			—				—
CONSOLIDATED NET INCOME (loss), BASIC	$	0.10		$	—			$	0.10
Income (loss) from continuing operations, diluted	$	0.08		$	—			$	0.08
Loss from discontinued operations, diluted	—			—				—
CONSOLIDATED NET INCOME (LOSS), DILUTED	$	0.08		$	—			$	0.08
SHARES USED IN COMPUTING CONSOLIDATED NET INCOME (LOSS) PER COMMON SHARE:
BASIC	96,633			—				96,633
DILUTED	116,884			—				116,884
COMPREHENSIVE INCOME (LOSS):
Consolidated net income (loss)	$	9,828		$	(334	)		$	9,494
Foreign currency translation loss, net of tax of ($878) for the quarter ended March 31, 2014	1,705			—				1,705
COMPREHENSIVE INCOME (LOSS)	$	11,533		$	(334	)		$	11,199

The effect of the restatement on the previously filed consolidated statement of cash flows for the three month period ended March 31, 2014 is as follows, in thousands:

	Three month period ended March 31, 2014
	As Previously Restated			Restatement Adjustment				As Restated
OPERATING ACTIVITIES:
Consolidated net income	$	9,828		$	(334	)	(h)	$	9,494
Loss from discontinued operations, net of tax	—			—				—
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization	6,675			—				6,675
Amortization of deferred financing fees	2,129			(1,903		)	(h)	226
Amortization of favorable (unfavorable) contracts	18			—				18
Amortization of inventory step-up	—			—				—
Non-cash stock compensation expense	1,282			—				1,282
Non-cash interest expense	1,249			—				1,249
Deferred income taxes, net	(1,689		)	(33		)	(i)	(1,722		)
Excess tax benefit from stock compensation	(33		)	—				(33		)
Changes in operating assets and liabilities, net of business acquisitions:
Trade accounts receivable, net	(450		)	—				(450		)
Inventories, net	(5,987		)	—				(5,987		)
Prepaid expenses and other current assets	1,026			—				1,026
Trade accounts payable	6,100			—				6,100
Accrued expenses and other liabilities	3,228			2,270			(i)	5,498
NET CASH PROVIDED BY OPERATING ACTIVITIES	23,376			—				23,376
INVESTING ACTIVITIES:
Payments for acquisitions and equity investments, net of cash acquired	(7,500		)	—				(7,500		)
Purchases of property, plant and equipment	(5,198		)	—				(5,198		)
Distributions from unconsolidated joint venture	—			—				—
NET CASH USED IN INVESTING ACTIVITIES	(12,698		)	—				(12,698		)
FINANCING ACTIVITIES:
Proceeds from issuances of debt	—			—				—
Proceeds under stock option and stock purchase plans	1,022			—				1,022
Payments of contingent acquisition liabilities	—			—				—
Debt financing costs	(408		)	—				(408		)
Proceeds from warrant exercises	—			—				—
Excess tax benefits from stock compensation	33			—				33
Debt repayment	—			—				—
NET CASH PROVIDED BY FINANCING ACTIVITIES	647			—				647
Effect of changes in exchange rates on cash and cash equivalents	103			—				103
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	11,428			—				11,428
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	34,178			—				34,178
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	45,606		$	—			$	45,606
SUPPLEMENTAL DISCLOSURES:
Amount paid for interest	$	129		$	—			$	129
Amount paid for income taxes, net of refunds received	$	1,806		$	—			$	1,806

Schedule Of Balance Sheet Information [Table Text Block]

Quarter period ended March 31, 2014

QUARTERLY CONSOLIDATED BALANCE SHEETS

(In Thousands, Except Share Data)

	March 31, 2014 (as Restated) (Unaudited)			December 31, 2013
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	45,606		$	34,178
Trade accounts receivable, net	65,500			64,998
Inventories, net	62,013			55,982
Deferred taxes, current	8,038			7,945
Available for sale security, current	—			—
Prepaid expenses and other current assets	4,559			5,753
TOTAL CURRENT ASSETS	185,716			168,856
PROPERTY, PLANT AND EQUIPMENT, NET	87,675			82,108
OTHER LONG-TERM ASSETS
Goodwill	30,437			29,831
Product licensing rights, net	122,933			115,900
Other intangibles, net	14,283			14,605
Deferred financing costs, net	5,473			5,676
Deferred taxes, non-current	3,330			1,643
Long-term investments	10,012			10,006
Other non-current assets	3,556			3,180
TOTAL OTHER LONG-TERM ASSETS	190,024			180,841
TOTAL ASSETS	$	463,415		$	431,805
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Trade accounts payable	$	30,632		$	22,999
Purchase consideration payable, current	18,898			14,728
Income taxes payable	8,739			1,459
Accrued royalties	6,480			6,004
Accrued compensation	4,453			7,692
Current maturities of long-term debt	—			—
Accrued administrative fees	2,110			2,544
Accrued expenses and other liabilities	6,929			5,819
TOTAL CURRENT LIABILITIES	78,241			61,245
LONG-TERM LIABILITIES
Long-term debt	109,825			108,750
Deferred tax liability, non-current	—			—
Lease incentive obligations and other long-term liabilities	1,634			1,630
TOTAL LONG-TERM LIABILITIES	111,459			110,380
TOTAL LIABILITIES	189,700			171,625
SHAREHOLDERS’ EQUITY
Common stock, no par value — 150,000,000 shares authorized; 96,697,545 and 96,569,186 shares issued and outstanding at March 31, 2014 and December 31, 2013, respectively	241,571			239,235
Warrants to acquire common stock	17,946			17,946
Retained earnings	24,860			15,366
Accumulated other comprehensive loss	(10,662		)	(12,367		)
TOTAL SHAREHOLDERS’ EQUITY	273,715			260,180
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	463,415		$	431,805

	June 30, 2014 (as Restated) (Unaudited)			December 31, 2013
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	107,916		$	34,178
Trade accounts receivable, net	128,774			64,998
Inventories, net	113,666			55,982
Deferred taxes, current	39,893			7,945
Available for sale security, current	—			—
Prepaid expenses and other current assets	12,277			5,753
TOTAL CURRENT ASSETS	402,526			168,856
PROPERTY, PLANT AND EQUIPMENT, NET	135,464			82,108
OTHER LONG-TERM ASSETS
Goodwill	186,365			29,831
Product licensing rights, net	429,788			115,900
Other intangibles, net	34,803			14,605
Deferred financing costs, net	18,666			5,676
Deferred taxes, non-current	2,451			1,643
Long-term investments	10,971			10,006
Other non-current assets	579			3,180
TOTAL OTHER LONG-TERM ASSETS	683,623			180,841
TOTAL ASSETS	$	1,221,613		$	431,805
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Trade accounts payable	$	43,454		$	22,999
Purchase consideration payable, current	24,003			14,728
Income taxes payable	—			1,459
Accrued royalties	7,072			6,004
Accrued compensation	11,058			7,692
Current maturities of long-term debt	4,500			—
Accrued administrative fees	4,475			2,544
Accrued expenses and other liabilities	18,829			5,819
TOTAL CURRENT LIABILITIES	113,391			61,245
LONG-TERM LIABILITIES
Long-term debt	706,420			108,750
Deferred tax liability, non-current	115,428			—
Lease incentive obligations and other long-term liabilities	2,165			1,630
TOTAL LONG-TERM LIABILITIES	824,013			110,380
TOTAL LIABILITIES	937,404			171,625
SHAREHOLDERS’ EQUITY
Common stock, no par value — 150,000,000 shares authorized; 104,088,199 and 96,569,186 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively	271,420			239,235
Warrants to acquire common stock	—			17,946
Retained earnings	23,604			15,366
Accumulated other comprehensive loss	(10,815		)	(12,367		)
TOTAL SHAREHOLDERS’ EQUITY	284,209			260,180
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	1,221,613		$	431,805

	September 30, 2014 (as Restated) (Unaudited)			December 31, 2013
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	131,466		$	34,178
Trade accounts receivable, net	127,972			64,998
Inventories, net	132,116			55,982
Deferred taxes, current	63,976			7,945
Available for sale security, current	10,804			—
Prepaid expenses and other current assets	27,332			5,753
TOTAL CURRENT ASSETS	493,666			168,856
PROPERTY, PLANT AND EQUIPMENT, NET	139,374			82,108
OTHER LONG-TERM ASSETS
Goodwill	285,881			29,831
Product licensing rights, net	671,127			115,900
Other intangibles, net	251,156			14,605
Deferred financing costs, net	25,172			5,676
Deferred taxes, non-current	1,746			1,643
Long-term investments	211			10,006
Other non-current assets	2,377			3,180
TOTAL OTHER LONG-TERM ASSETS	1,237,670			180,841
TOTAL ASSETS	$	1,870,710		$	431,805
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Trade accounts payable	$	38,205		$	22,999
Purchase consideration payable, current	24,216			14,728
Income taxes payable	—			1,459
Accrued royalties	14,533			6,004
Accrued compensation	12,977			7,692
Current maturities of long-term debt	10,494			—
Accrued administrative fees	8,898			2,544
Accrued expenses and other liabilities	31,957			5,819
TOTAL CURRENT LIABILITIES	141,280			61,245
LONG-TERM LIABILITIES
Long-term debt	1,146,585			108,750
Deferred tax liability, non-current	270,775			—
Lease incentive obligations and other long-term liabilities	2,679			1,630
TOTAL LONG-TERM LIABILITIES	1,420,039			110,380
TOTAL LIABILITIES	1,561,319			171,625
SHAREHOLDERS’ EQUITY
Common stock, no par value — 150,000,000 shares authorized; 107,330,516 and 96,569,186 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively	309,331			239,235
Warrants to acquire common stock	—			17,946
Retained earnings	11,271			15,366
Accumulated other comprehensive loss	(11,211		)	(12,367		)
TOTAL SHAREHOLDERS’ EQUITY	309,391			260,180
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	1,870,710		$	431,805

	March 31, 2015 (Unaudited)			December 31, 2014 (As restated)
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	123,532		$	70,679
Trade accounts receivable, net	190,710			187,545
Inventories, net	149,403			135,197
Deferred taxes, current	39,564			38,411
Available for sale security, current	5,558			7,268
Prepaid expenses and other current assets	35,118			37,061
TOTAL CURRENT ASSETS	543,885			476,161
PROPERTY, PLANT AND EQUIPMENT, NET	175,991			144,196
OTHER LONG-TERM ASSETS
Goodwill	285,674			285,283
Product licensing rights, net	689,490			704,791
Other intangibles, net	254,590			255,612
Deferred financing costs, net	22,687			23,704
Deferred taxes, non-current	2,643			2,084
Long-term investments	129			211
Other non-current assets	1,248			1,863
TOTAL OTHER LONG-TERM ASSETS	1,256,462			1,273,548
TOTAL ASSETS	$	1,976,338		$	1,893,905
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Trade accounts payable	$	57,971		$	47,317
Purchase consideration payable, current	12,367			10,970
Income taxes payable	—			—
Accrued royalties	13,948			13,204
Accrued compensation	8,375			13,467
Current maturities of long-term debt	10,450			10,450
Accrued administrative fees	36,312			40,870
Accrued expenses and other liabilities	14,428			14,576
TOTAL CURRENT LIABILITIES	153,851			150,854
LONG-TERM LIABILITIES
Long-term debt	1,110,458			1,114,481
Deferred tax liability, non-current	263,466			269,428
Lease incentive obligations and other long-term liabilities	6,388			2,836
TOTAL LONG-TERM LIABILITIES	1,380,312			1,386,745
TOTAL LIABILITIES	1,534,163			1,537,599
SHAREHOLDERS’ EQUITY
Common stock, no par value — 150,000,000 shares authorized; 114,332,873 and 111,734,901 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively	388,475			342,252
Warrants to acquire common stock	—			—
Retained earnings	66,788			29,250
Accumulated other comprehensive loss	(13,088		)	(15,195		)
TOTAL SHAREHOLDERS’ EQUITY	442,175			356,307
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	1,976,338		$	1,893,905

	June 30, 2015 (Unaudited)			December 31, 2014 (As restated)
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	257,090		$	70,679
Trade accounts receivable, net	130,812			187,545
Inventories, net	156,315			135,197
Deferred taxes, current	40,717			38,411
Available for sale security, current	5,632			7,268
Prepaid expenses and other current assets	16,447			37,061
TOTAL CURRENT ASSETS	607,013			476,161
PROPERTY, PLANT AND EQUIPMENT, NET	179,239			144,196
OTHER LONG-TERM ASSETS
Goodwill	285,356			285,283
Product licensing rights, net	674,687			704,791
Other intangibles, net	251,283			255,612
Deferred financing costs, net	22,612			23,704
Deferred taxes, non-current	2,982			2,084
Long-term investments	130			211
Other non-current assets	1,282			1,863
TOTAL OTHER LONG-TERM ASSETS	1,238,332			1,273,548
TOTAL ASSETS	$	2,024,584		$	1,893,905
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Trade accounts payable	$	45,536		$	47,317
Purchase consideration payable, current	4,904			10,970
Income taxes payable	3,525			—
Accrued royalties	13,716			13,204
Accrued compensation	11,286			13,467
Current maturities of long-term debt	53,971			10,450
Accrued administrative fees	45,229			40,870
Accrued expenses and other liabilities	20,813			14,576
TOTAL CURRENT LIABILITIES	198,980			150,854
LONG-TERM LIABILITIES
Long-term debt	1,026,713			1,114,481
Deferred tax liability, non-current	256,035			269,428
Lease incentive obligations and other long-term liabilities	6,910			2,836
TOTAL LONG-TERM LIABILITIES	1,289,658			1,386,745
TOTAL LIABILITIES	1,488,638			1,537,599
SHAREHOLDERS’ EQUITY
Common stock, no par value — 150,000,000 shares authorized; 119,199,049 and 111,734,901shares issued and outstanding at June 30, 2015 and December 31, 2014, respectively	449,742			342,252
Warrants to acquire common stock	—			—
Retained earnings	99,296			29,250
Accumulated other comprehensive loss	(13,092		)	(15,195		)
TOTAL SHAREHOLDERS’ EQUITY	535,946			356,307
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	2,024,584		$	1,893,905

	September 30, 2015 (Unaudited)			December 31, 2014 (As restated)
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	314,465		$	70,679
Trade accounts receivable, net	138,920			187,545
Inventories, net	175,851			135,197
Deferred taxes, current	41,871			38,411
Available for sale security, current	5,637			7,268
Prepaid expenses and other current assets	22,102			37,061
TOTAL CURRENT ASSETS	698,846			476,161
PROPERTY, PLANT AND EQUIPMENT, NET	177,433			144,196
OTHER LONG-TERM ASSETS
Goodwill	284,708			285,283
Product licensing rights, net	699,443			704,791
Other intangibles, net	212,360			255,612
Deferred financing costs, net	24,263			23,704
Deferred taxes, non-current	3,337			2,084
Long-term investments	129			211
Other non-current assets	748			1,863
TOTAL OTHER LONG-TERM ASSETS	1,224,988			1,273,548
TOTAL ASSETS	$	2,101,267		$	1,893,905
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Trade accounts payable	$	57,765		$	47,317
Purchase consideration payable, current	4,936			10,970
Income taxes payable	15,489			—
Accrued royalties	14,452			13,204
Accrued compensation	15,958			13,467
Current maturities of long-term debt	53,450			10,450
Accrued administrative fees	46,929			40,870
Accrued expenses and other liabilities	28,767			14,576
TOTAL CURRENT LIABILITIES	237,746			150,854
LONG-TERM LIABILITIES
Long-term debt	1,024,100			1,114,481
Deferred tax liability, non-current	248,279			269,428
Lease incentive obligations and other long-term liabilities	6,640			2,836
TOTAL LONG-TERM LIABILITIES	1,279,019			1,386,745
TOTAL LIABILITIES	1,516,765			1,537,599
SHAREHOLDERS’ EQUITY
Common stock, no par value — 150,000,000 shares authorized; 119,313,203 and 111,734,901 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	453,940			342,252
Warrants to acquire common stock	—			—
Retained earnings	147,263			29,250
Accumulated other comprehensive loss	(16,701		)	(15,195		)
TOTAL SHAREHOLDERS’ EQUITY	584,502			356,307
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	2,101,267		1,893,905

Schedule of Income Statement Information [Table Text Block]

QUARTERLY CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In Thousands, Except Share Data)

(Unaudited)

	First Quarter (as Restated)			First Quarter
	2014			2013
Revenues	$	90,622		$	73,854
Cost of sales (exclusive of amortization of intangibles included below)	40,966			34,709
GROSS PROFIT	49,656			39,145
Selling, general and administrative expenses	16,586			12,335
Acquisition-related costs	454			519
Research and development expenses	4,419			5,969
Amortization of intangibles	4,757			1,733
TOTAL OPERATING EXPENSES	26,216			20,556
OPERATING INCOME	23,440			18,589
Amortization of deferred financing costs	(4,251		)	(204		)
Interest expense, net	(2,161		)	(2,204		)
Other non-operating income (expense), net	567			76
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	17,595			16,257
Income tax provision (benefit)	8,101			5,415
INCOME (LOSS) FROM CONTINUING OPERATIONS	$	9,494		$	10,842
(Loss) from discontinued operations, net of tax	—			—
NET INCOME (LOSS)	$	9,494		$	10,842
NET INCOME (LOSS) PER SHARE:
Income (loss) from continuing operations, basic	$	0.10		$	0.11
(Loss) from discontinued operations, basic	$	—		$	—
NET INCOME (LOSS), BASIC	$	0.10		$	0.11
Income (loss) from continuing operations, diluted	$	0.08		$	0.10
(Loss) from discontinued operations, diluted	$	—		$	—
NET INCOME (LOSS), DILUTED	$	0.08		$	0.10
SHARES USED IN COMPUTING NET INCOME (LOSS) PER SHARE:
BASIC	96,633			95,926
DILUTED	116,884			111,551
COMPREHENSIVE INCOME (LOSS):
Consolidated net income (loss)	$	9,494		$	10,842
Unrealized holding gain on available-for-sale securities, net of tax	—			—
Foreign currency translation (loss) income, net of tax of ($878) and ($184) for the quarters ended March 31, 2014 and 2013, respectively.	1,705			358
COMPREHENSIVE INCOME (LOSS)	$	11,199		$	11,200

	Second Quarter			Second Quarter			YTD -Second Quarter			YTD – Second Quarter
	2014 (as Restated)			2013			2014 (as Restated)			2013
Revenues	$	133,872		$	77,012		$	224,494		$	150,866
Cost of sales (exclusive of amortization of intangibles included below)	73,000			34,920			113,967			69,629
GROSS PROFIT	60,871			42,092			110,527			81,237
Selling, general and administrative expenses	21,168			13,113			37,754			25,448
Acquisition-related costs	20,940			—			21,394			519
Research and development expenses	9,588			5,051			14,007			11,020
Amortization of intangibles	8,439			1,677			13,196			3,410
TOTAL OPERATING EXPENSES	60,135			19,841			86,351			40,397
OPERATING INCOME	736			22,251			24,176			40,840
Amortization of deferred financing costs	(2,346		)	(207		)	(6,597		)	(411		)
Interest expense, net	(7,917		)	(2,028		)	(10,076		)	(4,232		)
Gain from product divestiture	8,490			—			8,490			—
Bargain purchase gain	—			—			—			—
Other non-operating income (expense), net	(214		)	(34		)	351			42
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(1,251		)	19,982			16,344			36,239
Income tax provision (benefit)	(499		)	7,345			7,602			12,760
INCOME (LOSS) FROM CONTINUING OPERATIONS	$	(752	)	$	12,637		$	8,742		$	23,479
(Loss) from discontinued operations, net of tax	(504		)	—			(504		)	—
NET INCOME (LOSS)	$	(1,256	)	$	12,637		$	8,238		$	23,479
NET INCOME (LOSS) PER SHARE:
Income (loss) from continuing operations, basic	$	(0.01	)	$	0.13		$	0.09		$	0.24
(Loss) from discontinued operations, basic	$	—		$	—		$	(0.01	)	$	—
NET INCOME (LOSS), BASIC	$	(0.01	)	$	0.13		$	0.08		$	0.24
Income (loss) from continuing operations, diluted	$	(0.01	)	$	0.11		$	0.07		$	0.21
(Loss) from discontinued operations, diluted	$	—		$	—		$	—		$	—
NET INCOME (LOSS), DILUTED	$	(0.01	)	$	0.11		$	0.07		$	0.21
SHARES USED IN COMPUTING NET INCOME (LOSS) PER SHARE:
BASIC	103,183			96,122			99,926			96,025
DILUTED	103,183			112,328			117,576			112,010
COMPREHENSIVE INCOME (LOSS):
Consolidated net income (loss)	$	(1,256	)	$	12,637		$	8,238		$	23,479
Foreign currency translation (loss) income, net of tax of $78 and $2,564 in the quarters ended June 30, 2014 and 2013, respectively and ($799) and $2,379 in the year to date periods ended June 30, 2014 and 2013, respectively	(153		)	(4,979		)	1,552			(4,621		)
COMPREHENSIVE INCOME (LOSS)	$	(1,409	)	$	7,658		$	9,790		$	18,858

	Third  Quarter			Third Quarter			YTD -Third  Quarter			YTD — Third  Quarter
	2014 (as Restated)			2013			2014 (as Restated)			2013
Revenues	$	127,698		$	81,892		$	352,192		$	232,758
Cost of sales (exclusive of amortization of intangibles included below)	82,198			38,195			196,165			107,824
GROSS PROFIT	45,500			43,697			156,027			124,934
Selling, general and administrative expenses	26,799			13,645			64,553			39,093
Acquisition-related costs	8,159			1,459			29,553			1,978
Research and development expenses	8,758			4,837			22,765			15,857
Amortization of intangibles	13,814			1,568			27,010			4,978
TOTAL OPERATING EXPENSES	57,530			21,509			143,881			61,906
OPERATING INCOME (LOSS)	(12,030		)	22,188			12,146			63,028
Amortization of deferred financing costs	(2,272		)	(211		)	(8,869		)	(622		)
Interest expense, net	(11,804		)	(2,155		)	(21,880		)	(6,387		)
Gain from product divestiture	847			—			9,337			—
Bargain purchase gain	—			—			—			—
Other non-operating income (expense), net	1,012			160			1,363			202
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(24,247		)	19,982			(7,903		)	56,221
Income tax provision (benefit)	(11,914		)	7,777			(4,312		)	20,537
INCOME (LOSS) FROM CONTINUING OPERATIONS	$	(12,333	)	$	12,205		$	(3,591	)	$	35,684
(Loss) from discontinued operations, net of tax	—			—			(504		)	—
NET INCOME (LOSS)	$	(12,333	)	$	12,205		$	(4,095	)	$	35,684
NET INCOME (LOSS) PER SHARE:
Income (loss) from continuing operations, basic	$	(0.12	)	$	0.13		$	(0.04	)	$	0.37
(Loss) from discontinued operations, basic	—			—			$	—		—
NET INCOME (LOSS), BASIC	$	(0.12	)	$	0.13		$	(0.04	)	$	0.37
Income (loss) from continuing operations, diluted	$	(0.12	)	$	0.11		$	(0.04	)	$	0.32
(Loss) from discontinued operations, diluted	—			—			$	—		—
NET INCOME (LOSS), DILUTED	$	(0.12	)	$	0.11		$	(0.04	)	$	0.32
SHARES USED IN COMPUTING NET INCOME (LOSS) PER SHARE:
BASIC	105,438			96,238			101,784			96,096
DILUTED	105,438			113,717			101,784			112,644
COMPREHENSIVE INCOME (LOSS):
Consolidated net income (loss)	$	(12,333	)	$	12,205		$	(4,095	)	$	35,684
Unrealized holding gain on available-for-sale securities, net of tax of ($631) and $0 for the quarters ended June 30, 2014 and 2013, respectively and net of tax of ($631) and $0 for year to date period ended June 30, 2014 and 2013, respectively.	1,070			—			1,070			—
Foreign currency translation (loss) income, net of tax of $755 and $1,340 for the quarters ended June 30, 2014 and 2013, respectively and net of tax of $44 and $3,720 for the year to date period ended June 30, 2014 and 2013, respectively.	(1,466		)	(2,603		)	86			(7,224		)
COMPREHENSIVE INCOME (LOSS)	$	(12,729	)	$	9,602		$	(2,939	)	$	28,460

	Fourth  Quarter			Fourth  Quarter
	2014 (as Restated)			2013
Revenues	$	202,856		$	84,953
Cost of sales (exclusive of amortization of intangibles included below)	97,523			37,983
GROSS PROFIT	105,333			46,970
Selling, general and administrative expenses	28,402			14,415
Acquisition-related costs	3,287			934
Research and development expenses	8,491			4,001
Amortization of intangibles	16,483			2,444
TOTAL OPERATING EXPENSES	56,663			21,794
OPERATING INCOME	48,670			25,176
Amortization of deferred financing costs	(1,116		)	(220		)
Interest expense, net	(13,777		)	(2,262		)
Equity in earnings of unconsolidated joint venture	—			80
Gain (loss) from product divestiture	(40		)	—
Bargain purchase gain	—			3,707
Other non-operating income (expense), net	(492		)	193
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	33,245			26,674
Income tax provision (benefit)	15,266			9,996
INCOME (LOSS) FROM CONTINUING OPERATIONS	$	17,979		$	16,678
(Loss) from discontinued operations, net of tax	$	—		$	—
NET INCOME (LOSS)	$	17,979		$	16,678
NET INCOME (LOSS) PER SHARE:
Income (loss) from continuing operations, basic	$	0.17		$	0.17
(Loss) from discontinued operations, basic	$	—		$	—
NET INCOME (LOSS), BASIC	$	0.17		$	0.17
Income (loss) from continuing operations, diluted	$	0.16		$	0.13
(Loss) from discontinued operations, diluted	$	—		—
NET INCOME (LOSS), DILUTED	$	0.16		$	0.13
SHARES USED IN COMPUTING NET INCOME (LOSS) PER SHARE:
BASIC	108,515			96,431
DILUTED	124,491			113,898
COMPREHENSIVE INCOME (LOSS):
Consolidated net income (loss)	$	17,979		$	16,678
Unrealized holding loss on available-for-sale securities, net of tax of $1,294	(2,193		)	—
Foreign currency translation (loss) income, net of tax of $922 and ($392) as of December 31, 2014 and 2013, respectively	(1,790		)	761
COMPREHENSIVE INCOME (LOSS)	$	13,996		$	17,439

	First Quarter			First Quarter (as Restated)
	2015			2014
Revenues	$	227,378		$	90,622
Cost of sales (exclusive of amortization of intangibles included below)	97,215			40,966
GROSS PROFIT	130,163			49,656
Selling, general and administrative expenses	29,986			16,586
Acquisition-related costs	1,257			454
Research and development expenses	9,276			4,419
Amortization of intangibles	16,377			4,757
TOTAL OPERATING EXPENSES	56,896			26,216
OPERATING INCOME	73,267			23,440
Amortization of deferred financing costs	(996		)	(4,251		)
Interest expense, net	(13,480		)	(2,161		)
Gain from product divestiture	—			—
Bargain purchase gain	849			—
Other non-operating income (expense), net	(1,312		)	567
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	58,328			17,595
Income tax provision (benefit)	20,790			8,101
INCOME (LOSS) FROM CONTINUING OPERATIONS	$	37,538		$	9,494
(Loss) from discontinued operations, net of tax	—			—
NET INCOME (LOSS)	$	37,538		$	9,494
NET INCOME (LOSS) PER SHARE:
Income (loss) from continuing operations, basic	$	0.33		$	0.10
(Loss) from discontinued operations, basic	$	—		$	—
NET INCOME (LOSS), BASIC	$	0.33		$	0.10
Income (loss) from continuing operations, diluted	$	0.31		$	0.08
(Loss) from discontinued operations, diluted	$	—		$	—
NET INCOME (LOSS), DILUTED	$	0.31		$	0.08
SHARES USED IN COMPUTING NET INCOME (LOSS) PER SHARE:
BASIC	113,352			96,633
DILUTED	125,377			116,884
COMPREHENSIVE INCOME (LOSS):
Consolidated net income (loss)	$	37,538		$	9,494
Unrealized holding gain on available-for-sale securities, net of tax of ($59)	101			—
Foreign currency translation (loss) income, net of tax of ($1,034) and ($878) for the quarters ended March 31, 2015 and 2014, respectively.	2,008			1,705
COMPREHENSIVE INCOME (LOSS)	$	39,647		$	11,199

	Second Quarter			Second Quarter			YTD -Second Quarter			YTD – Second Quarter
	2015			2014 (as Restated)			2015			2014 (as Restated)
Revenues	$	220,920		$	133,872		$	448,298		$	224,494
Cost of sales (exclusive of amortization of intangibles included below)	92,513			73,000			189,728			113,967
GROSS PROFIT	128,407			60,871			258,570			110,527
Selling, general and administrative expenses	35,208			21,168			65,194			37,754
Acquisition-related costs	225			20,940			1,482			21,394
Research and development expenses	10,588			9,588			19,864			14,007
Amortization of intangibles	16,284			8,439			32,661			13,196
TOTAL OPERATING EXPENSES	62,305			60,135			119,201			86,351
OPERATING INCOME	66,102			736			139,369			24,176
Amortization of deferred financing costs	(1,026		)	(2,346		)	(2,022		)	(6,597		)
Interest expense, net	(13,235		)	(7,917		)	(26,715		)	(10,076		)
Gain from product divestiture	—			8,490			—			8,490
Bargain purchase gain	—			—			849			—
Other non-operating income (expense), net	(1,483		)	(214		)	(2,795		)	351
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	50,358			(1,251		)	108,686			16,344
Income tax provision (benefit)	17,850			(499		)	38,640			7,602
INCOME (LOSS) FROM CONTINUING OPERATIONS	$	32,508		$	(752	)	$	70,046		$	8,742
(Loss) from discontinued operations, net of tax	$	—		$	(504	)	$	—		$	(504	)
NET INCOME (LOSS)	$	32,508		$	(1,256	)	$	70,046		$	8,238
NET INCOME (LOSS) PER SHARE:
Income (loss) from continuing operations, basic	$	0.28		$	(0.01	)	$	0.61		$	0.09
(Loss) from discontinued operations, basic	$	—		$	—		$	—		$	(0.01	)
NET INCOME (LOSS), BASIC	$	0.28		$	(0.01	)	$	0.61		$	0.08
Income (loss) from continuing operations, diluted	$	0.27		$	(0.01	)	$	0.57		$	0.07
(Loss) from discontinued operations, diluted	$	—		$	—		$	—		$	—
NET INCOME (LOSS), DILUTED	$	0.27		$	(0.01	)	$	0.57		$	0.07
SHARES USED IN COMPUTING NET INCOME (LOSS) PER SHARE:
BASIC	115,808			103,183			114,587			99,926
DILUTED	125,919			103,183			125,650			117,576
COMPREHENSIVE INCOME (LOSS):
Consolidated net income (loss)	$	32,508		$	(1,256	)	$	70,046		$	8,238
Unrealized holding gain on available-for-sale securities, net of tax of ($53) for the three month period ended June 30, 2015 and ($112) for the six month period ended June 30, 2015.	89			—			190			—
Foreign currency translation (loss) income, net of tax of $49 and $79 for the three month periods ended June 30, 2015 and 2014, respectively and ($984) and ($799) for the six months period ended June 30, 2015 and 2014, respectively.	(95		)	(153		)	1,913			1,552
COMPREHENSIVE INCOME (LOSS)	$	32,502		$	(1,409	)	$	72,149		$	9,790

	Third Quarter			Third Quarter			YTD -Third Quarter			YTD — Third Quarter
	2015			2014 (as Restated)			2015			2014 (as Restated)
Revenues	$	256,801		$	127,698		$	705,099		$	352,192
Cost of sales (exclusive of amortization of intangibles included below)	93,789			82,198			283,517			196,165
GROSS PROFIT	163,012			45,500			421,582			156,027
Selling, general and administrative expenses	45,031			26,799			110,225			64,553
Acquisition-related costs	230			8,159			1,712			29,553
Research and development expenses	10,439			8,758			30,303			22,765
Amortization of intangibles	16,545			13,814			49,206			27,010
TOTAL OPERATING EXPENSES	72,245			57,530			191,446			143,881
OPERATING INCOME (LOSS)	90,767			(12,030		)	230,136			12,146
Amortization of deferred financing costs	(1,086		)	(2,272		)	(3,108		)	(8,869		)
Interest expense, net	(12,652		)	(11,804		)	(39,367		)	(21,880		)
Gain from product divestiture	—			847			—			9,337
Bargain purchase gain	—			—			849			—
Other non-operating income (expense), net	(3,014		)	1,012			(5,809		)	1,363
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	74,015			(24,247		)	182,701			(7,903		)
Income tax provision (benefit)	26,048			(11,914		)	64,688			(4,312		)
INCOME (LOSS) FROM CONTINUING OPERATIONS	$	47,967		$	(12,333	)	$	118,013		$	(3,591	)
(Loss) from discontinued operations, net of tax	$	—		$	—		$	—		$	(504	)
NET INCOME (LOSS)	$	47,967		$	(12,333	)	$	118,013		$	(4,095	)
NET INCOME (LOSS) PER SHARE:
Income (loss) from continuing operations, basic	$	0.40		$	(0.12	)	$	1.02		$	(0.04	)
(Loss) from discontinued operations, basic	$	—		$	—		$	—		$	—
NET INCOME (LOSS), BASIC	$	0.40		$	(0.12	)	$	1.02		$	(0.04	)
Income (loss) from continuing operations, diluted	$	0.39		$	(0.12	)	$	0.96		$	(0.04	)
(Loss) from discontinued operations, diluted	$	—		$	—		$	—		$	—
NET INCOME (LOSS), DILUTED	$	0.39		$	(0.12	)	$	0.96		$	(0.04	)
SHARES USED IN COMPUTING NET INCOME (LOSS) PER SHARE:
BASIC	119,260			105,438			116,162			101,784
DILUTED	125,891			105,438			125,738			101,784
COMPREHENSIVE INCOME (LOSS):
Consolidated net income (loss)	$	47,967		$	(12,333	)	$	118,013		$	(4,095	)
Unrealized holding gain on available-for-sale securities, net of tax of $163 and ($631) for the three month periods ended September 30, 2015 and 2014, respectively and ($51) and ($631) for the nine months period ended September 30, 2015 and 2014, respectively.	(277		)	1,070			(87		)	1,070
Foreign currency translation (loss) income, net of tax of $1,714 and $755 for the three month periods ended September 30, 2015 and 2014, respectively and $731 and ($44) for the nine months period ended September 30, 2015 and 2014, respectively.	(3,332		)	(1,466		)	(1,419		)	86
COMPREHENSIVE INCOME (LOSS)	$	44,358		$	(12,729	)	$	116,507		$	(2,939	)

	Fourth Quarter			Fourth Quarter
	2015			2014 (As restated)
Revenues	$	279,977		$	202,856
Cost of sales (exclusive of amortization of intangibles included below)	105,547			97,523
GROSS PROFIT	174,430			105,333
Selling, general and administrative expenses	51,980			28,402
Acquisition-related costs	129			3,287
Research and development expenses	10,404			8,491
Amortization of intangibles	17,066			16,483
Intangible impairment	30,376			—
TOTAL OPERATING EXPENSES	109,955			56,663
OPERATING INCOME	64,475			48,670
Amortization of deferred financing costs	(1,175		)	(1,116		)
Interest expense, net	(12,606		)	(13,777		)
Gain (loss) from product divestiture	—			(40		)
Other non-operating income (expense), net	(1,239		)	(492		)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	49,455			33,245
Income tax provision (benefit)	16,670			15,266
INCOME (LOSS) FROM CONTINUING OPERATIONS	$	32,785		$	17,979
(Loss) from discontinued operations, net of tax	$	—		$	—
NET INCOME (LOSS)	$	32,785		$	17,979
NET INCOME (LOSS) PER SHARE:
Income (loss) from continuing operations, basic	$	0.27		$	0.17
(Loss) from discontinued operations, basic	$	—		$	—
NET INCOME (LOSS), BASIC	$	0.27		$	0.17
Income (loss) from continuing operations, diluted	$	0.27		$	0.16
(Loss) from discontinued operations, diluted	$	—		$	—
NET INCOME (LOSS), DILUTED	$	0.27		$	0.16
SHARES USED IN COMPUTING NET INCOME (LOSS) PER SHARE:
BASIC	119,390			108,515
DILUTED	125,698			124,491
COMPREHENSIVE INCOME (LOSS):
Consolidated net income (loss)	$	32,785		$	17,979
Unrealized holding loss on available-for-sale securities, net of tax of ($113) and $1,294 for the three month periods ended December 31, 2015 and 2014, respectively.	191			(2,193		)
Foreign currency translation (loss) income, net of tax of $326 and $922 for the three month periods ended December 31, 2015 and 2014, respectively.	(632		)	(1,790		)
COMPREHENSIVE INCOME (LOSS)	$	32,344		$	13,996

Schedule of Cash Flow Information [Table Text Block]

QUARTERLY CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

(Unaudited)

	Three Months Ended March 31, 2014 (as Restated)			Three Months Ended March 31, 2013
OPERATING ACTIVITIES:
Consolidated net income	$	9,494		$	10,842
Loss from discontinued operations, net of tax	—			—
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization	6,675			3,289
Amortization of deferred financing fees	226			204
Amortization of favorable (unfavorable) contracts	18			(159		)
Amortization of inventory step-up	—			—
Non-cash stock compensation expense	1,282			1,703
Non-cash interest expense	1,249			1,226
Deferred income taxes, net	(1,722		)	798
Excess tax benefit from stock compensation	(33		)	(238		)
Non-cash settlement of product warranty liability	—			—
Equity in earnings of unconsolidated joint venture	—			(76		)
Changes in operating assets and liabilities, net of business acquisitions:
Trade accounts receivable, net	(450		)	(7,958
Inventories, net	(5,987		)	(1,441		)
Prepaid expenses and other current assets	1,026			1,002
Trade accounts payable	6,100			(1,861		)
Accrued expenses and other liabilities	5,498			(409		)
NET CASH PROVIDED BY OPERATING ACTIVITIES	23,376			6,922
INVESTING ACTIVITIES:
Payments for acquisitions and equity investments, net of cash acquired	(7,500		)	(269		)
Purchases of property, plant and equipment	(5,198		)	(2,689		)
Distributions from unconsolidated joint venture	—			—
NET CASH USED IN INVESTING ACTIVITIES	(12,698		)	(2,958		)
FINANCING ACTIVITIES:
Proceeds from issuances of debt	—			—
Proceeds under stock option and stock purchase plans	1,022			868
Payments of contingent acquisition liabilities	—			—
Debt financing costs	(408		)	—
Proceeds from warrant exercises	—			—
Excess tax benefits from stock compensation	33			238
Debt repayment	—			—
NET CASH PROVIDED BY FINANCING ACTIVITIES	647			1,106
Effect of changes in exchange rates on cash and cash equivalents	103			12
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	11,428			5,082
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	34,178			40,781
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	45,606		$	45,863
SUPPLEMENTAL DISCLOSURES:
Amount paid for interest	$	129		$	31
Amount paid for income taxes, net of refunds received	$	1,806		$	2

	Six Months Ended June 30, 2014 (as Restated)			Six Months Ended June 30, 2013
OPERATING ACTIVITIES:
Consolidated net income	$	8,238		$	23,479
Loss from discontinued operations, net of tax	504			—
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization	18,565			6,651
Amortization of deferred financing fees	6,599			411
Amortization of favorable (unfavorable) contracts	35			(318		)
Amortization of inventory step-up	3,559			—
Non-cash stock compensation expense	3,275			4,244
Non-cash interest expense	2,655			2,263
Non-cash gain on bargain purchase	—			—
Gain from product divestiture	(9,329		)	—
Deferred income taxes, net	(20,103		)	1,201
Excess tax benefit from stock compensation	(722		)	(745		)
Non-cash settlement of product warranty liability	—			(1,299		)
Equity in earnings of unconsolidated joint venture	—			(76		)
Loss on extinguishment of debt	—			—
Gain on sale of available for sale security	—			—
Changes in operating assets and liabilities, net of business acquisitions:
Trade accounts receivable, net	(13,716		)	(6,908		)
Inventories, net	(10,227		)	(4,428		)
Prepaid expenses and other current assets	55,636			538
Trade accounts payable	11,524			(151		)
Accrued expenses and other liabilities	(35,240		)	(3,464		)
NET CASH PROVIDED BY OPERATING ACTIVITIES	21,253			21,398
INVESTING ACTIVITIES:
Payments for acquisitions and equity investments, net of cash acquired	(579,315		)	(513		)
Proceeds from disposal of assets	58,721			—
Payments for other intangible assets	(6,300		)	—
Purchases of property, plant and equipment	(11,912		)	(5,159		)
Distributions from unconsolidated joint venture	—			—
NET CASH USED IN INVESTING ACTIVITIES	(538,806		)	(5,672		)
FINANCING ACTIVITIES:
Proceeds from issuances of debt	600,000			—
Proceeds under stock option and stock purchase plans	2,071			1,265
Payments of contingent acquisition liabilities	—			—
Debt financing costs	(19,775		)	—
Proceeds from warrant exercises	8,171			—
Excess tax benefits from stock compensation	722			745
Debt repayment	—			—
NET CASH PROVIDED BY FINANCING ACTIVITIES	591,189			2,010
Effect of changes in exchange rates on cash and cash equivalents	102			(105		)
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	73,738			17,631
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	34,178			40,871
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	107,916		$	58,412
SUPPLEMENTAL DISCLOSURES:
Amount paid for interest	$	2,105		$	2,152
Amount paid for income taxes, net of refunds received	$	16,449		$	11,936

	Nine Months Ended September 30, 2014 (as Restated)			Nine Months Ended September 30, 2013
OPERATING ACTIVITIES:
Consolidated net income (loss)	$	(4,095	)	$	35,684
Loss from discontinued operations, net of tax	504			—
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization	37,270			9,925
Amortization of deferred financing fees	8,870			622
Amortization of favorable (unfavorable) contracts	53			(475		)
Amortization of inventory step-up	9,844			—
Non-cash stock compensation expense	5,065			5,674
Non-cash interest expense	3,955			3,426
Gain from product divestiture	(9,329		)	—
Deferred income taxes, net	(40,270		)	1,829
Excess tax benefit from stock compensation	(32,047		)	(1,192		)
Non-cash settlement of product warranty liability	—			(1,299		)
Equity in earnings of unconsolidated joint venture	—			(76		)
Loss on extinguishment of debt	—			—
Changes in operating assets and liabilities, net of business acquisitions:
Trade accounts receivable, net	(9,821		)	(10,858		)
Inventories, net	(14,037		)	(4,575		)
Prepaid expenses and other current assets	41,078			867
Trade accounts payable	1,888			1,444
Accrued expenses and other liabilities	14,429			1,414
NET CASH PROVIDED BY OPERATING ACTIVITIES	13,357			42,410
INVESTING ACTIVITIES:
Payments for acquisitions and equity investments, net of cash acquired	(929,772		)	(513		)
Proceeds from disposal of assets	58,750			—
Payments for other intangible assets	(8,498		)	—
Purchases of property, plant and equipment	(17,778		)	(7,936		)
Distributions from unconsolidated joint venture	—			—
NET CASH USED IN INVESTING ACTIVITIES	(897,298		)	(8,449		)
FINANCING ACTIVITIES:
Proceeds from issuances of debt	1,045,044			—
Proceeds under stock option and stock purchase plans	6,867			2,439
Payments of contingent acquisition liabilities	—			—
Debt financing costs	(28,365		)	(2,557		)
Proceeds from warrant exercises	8,171			—
Excess tax benefits from stock compensation	32,047			1,192
Debt repayment	(82,436		)	—
NET CASH PROVIDED BY FINANCING ACTIVITIES	981,328			1,074
Effect of changes in exchange rates on cash and cash equivalents	(99		)	(218		)
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	97,288			34,817
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	34,178			40,781
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	131,466		$	75,598
SUPPLEMENTAL DISCLOSURES
Amount paid for interest	$	8,944		$	2,178
Amount paid for income taxes, net of refunds received	$	6,226		$	18,690

	Three Months Ended March 31, 2015			Three Months Ended March 31, 2014 (as Restated)
OPERATING ACTIVITIES:
Consolidated net income	$	37,538		$	9,494
Loss from discontinued operations, net of tax	—			—
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization	21,109			6,675
Amortization of deferred financing fees	997			226
Amortization of favorable (unfavorable) contracts	18			18
Amortization of inventory step-up	4,682			—
Non-cash stock compensation expense	2,974			1,282
Non-cash interest expense	1,186			1,249
Non-cash gain on bargain purchase	(849		)	—
Gain from product divestiture	—			—
Deferred income taxes, net	(9,186)			(1,722		)
Excess tax benefit from stock compensation	(29,944		)	(33		)
Loss on extinguishment of debt	98			—
Gain on sale of available for sale security	146			—
Changes in operating assets and liabilities, net of business acquisitions:
Trade accounts receivable, net	384			(450		)
Inventories, net	(14,559		)	(5,987		)
Prepaid expenses and other current assets	2,896			1,026
Trade accounts payable	7,916			6,100
Accrued expenses and other liabilities	19,860			5,498
NET CASH PROVIDED BY OPERATING ACTIVITIES	45,266			23,376
INVESTING ACTIVITIES:
Payments for acquisitions and equity investments, net of cash acquired	(24,637		)	(7,500		)
Proceeds from disposal of assets	2,358			—
Payments for other intangible assets	—			—
Purchases of property, plant and equipment	(7,088		)	(5,198		)
Distributions from unconsolidated joint venture	—			—
NET CASH USED IN INVESTING ACTIVITIES	(29,367		)	(12,698		)
FINANCING ACTIVITIES:
Proceeds from issuances of debt	—			—
Proceeds under stock option and stock purchase plans	10,958			1,022
Payments of contingent acquisition liabilities	(1,500		)	—
Debt financing costs	—			(408		)
Proceeds from warrant exercises	—			—
Excess tax benefits from stock compensation	29,944			33
Debt repayment	(2,613		)	—
NET CASH PROVIDED BY FINANCING ACTIVITIES	36,789			647
Effect of changes in exchange rates on cash and cash equivalents	165			103
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	52,853			11,428
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	70,679			34,178
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	123,532		$	45,606
SUPPLEMENTAL DISCLOSURES
Amount paid for interest	$	11,836		$	129
Amount paid for income taxes, net of refunds received	$	238		$	1,806

	Six Months Ended June 30, 2015			Six Months Ended June 30, 2014 (as Restated)
OPERATING ACTIVITIES:
Consolidated net income	$	70,046		$	8,238
Loss from discontinued operations, net of tax	—			504
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization	44,742			18,565
Amortization of deferred financing fees	2,490			6,599
Amortization of favorable (unfavorable) contracts	35			35
Amortization of inventory step-up	4,682			3,559
Non-cash stock compensation expense	6,062			3,275
Non-cash interest expense	1,889			2,655
Non-cash gain on bargain purchase	(849		)	—
Gain from product divestiture	—			(9,329		)
Deferred income taxes, net	(18,288		)	(20,103		)
Excess tax benefit from stock compensation	(47,997		)	(722		)
Loss on extinguishment of debt	1,189			—
Gain on sale of available for sale security	230			—
Changes in operating assets and liabilities, net of business acquisitions:
Trade accounts receivable, net	60,449			(13,716		)
Inventories, net	(21,356		)	(10,227		)
Prepaid expenses and other current assets	21,452			55,636
Trade accounts payable	(3,623		)	11,524
Accrued expenses and other liabilities	59,896			(35,240		)
NET CASH PROVIDED BY OPERATING ACTIVITIES	181,049			21,253
INVESTING ACTIVITIES:
Payments for acquisitions and equity investments, net of cash acquired	(27,136		)	(579,315		)
Proceeds from disposal of assets	2,372			58,721
Payments for other intangible assets	(800		)	(6,300		)
Purchases of property, plant and equipment	(15,600		)	(11,912		)
Distributions from unconsolidated joint venture	—			—
NET CASH USED IN INVESTING ACTIVITIES	(41,164		)	(538,806		)
FINANCING ACTIVITIES:
Proceeds from issuances of debt	—			600,000
Proceeds under stock option and stock purchase plans	11,916			2,071
Payments of contingent acquisition liabilities	(6,492		)	—
Debt financing costs	(1,714		)	(19,775		)
Proceeds from warrant exercises	—			8,171
Excess tax benefits from stock compensation	47,997			722
Debt repayment	(5,225		)	—
NET CASH PROVIDED BY FINANCING ACTIVITIES	46,482			591,189
Effect of changes in exchange rates on cash and cash equivalents	44			102
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	186,411			73,738
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	70,679			34,178
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	257,090		$	107,916
SUPPLEMENTAL DISCLOSURE
Amount paid for interest	$	25,222		$	2,105
Amount paid (refunded) for income taxes, net of refunds received	$	(12,753	)	$	16,449

	Nine Months Ended September 30, 2015			Nine Months Ended September 30, 2014 (as Restated)
OPERATING ACTIVITIES:
Consolidated net income (loss)	$	118,013		$	(4,095	)
Loss from discontinued operations, net of tax	—			504
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization	63,835			37,270
Impairment of intangible assets	2,627			—
Amortization of deferred financing fees	3,576			8,870
Amortization of favorable (unfavorable) contracts	53			53
Amortization of inventory step-up	4,682			9,844
Non-cash stock compensation expense	9,270			5,065
Non-cash interest expense	2,342			3,955
Non-cash gain on bargain purchase	(849		)	—
Gain from product divestiture	—			(9,329		)
Deferred income taxes, net	(27,579		)	(40,270		)
Excess tax benefit from stock compensation	(47,997		)	(32,047		)
Loss on extinguishment of debt	1,211			—
Gain on sale of available for sale security	238			—
Changes in operating assets and liabilities, net of business acquisitions:
Trade accounts receivable, net	52,056			(9,821		)
Inventories, net	(41,177		)	(14,037		)
Prepaid expenses and other current assets	15,442			41,078
Trade accounts payable	9,357			1,888
Accrued expenses and other liabilities	86,999			14,429
NET CASH PROVIDED BY OPERATING ACTIVITIES	252,099			13,357
INVESTING ACTIVITIES:
Payments for acquisitions and equity investments, net of cash acquired	(26,908		)	(929,772		)
Proceeds from disposal of assets	2,459			58,750
Payments for other intangible assets	(3,135		)	(8,498		)
Purchases of property, plant and equipment	(21,628		)	(17,778		)
Distributions from unconsolidated joint venture	—			—
NET CASH USED IN INVESTING ACTIVITIES	(49,212		)	(897,298		)
FINANCING ACTIVITIES:
Proceeds from issuances of debt	—			1,045,044
Proceeds under stock option and stock purchase plans	11,917			6,867
Payments of contingent acquisition liabilities	(6,492		)	—
Debt financing costs	(4,457		)	(28,365		)
Proceeds from warrant exercises	—			8,171
Excess tax benefits from stock compensation	47,997			32,047
Debt repayment	(7,838		)	(82,436		)
NET CASH PROVIDED BY FINANCING ACTIVITIES	41,127			981,328
Effect of changes in exchange rates on cash and cash equivalents	(228		)	(99		)
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	243,786			97,288
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	70,679			34,178
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	314,465		$	131,466
SUPPLEMENTAL DISCLOSURE
Amount paid for interest	$	38,614		$	8,944
Amount paid (refunded) for income taxes, net of refunds received	$	(4,064	)	$	6,226

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The following table summarizes the basis used to measure the fair values of the Company’s financial instruments (amounts in thousands):

			Fair Value Measurements at Reporting Date, Using:
			Quoted Prices		Significant
			in Active		Other		Significant
			Markets for		Observable		Unobservable
	March 31,		Identical Items		Inputs		Inputs
Description	2014		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	45,606	$	45,606	$	—	$	—
Foreign currency forward contracts	787		—		787		—
Total assets	$	46,393	$	45,606	$	787	$	—
Purchase consideration payable	$	18,898	$	—	$	—	$	18,898
Total liabilities	$	18,898	$	—	$	—	$	18,898

			Quoted Prices		Significant
			in Active		Other		Significant
			Markets for		Observable		Unobservable
	December 31,		Identical Items		Inputs		Inputs
Description	2013		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	34,178	$	34,178	$	—	$	—
Foreign currency forward contracts	208		—		208		—
Total assets	$	34,386	$	34,178	$	208	$	—
Purchase consideration payable	$	14,728	$	—	$	—	$	14,728
Total liabilities	$	14,728	$	—	$	—	$	14,728

The following table summarizes the basis used to measure the fair values of the Company’s financial instruments (amounts in thousands):

			Fair Value Measurements at Reporting Date, Using:
			Quoted Prices		Significant
			in Active		Other		Significant
			Markets for		Observable		Unobservable
	June 30,		Identical Items		Inputs		Inputs
Description	2014		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	107,916	$	107,916	$	—	$	—
Foreign currency forward contracts	630		—		630		—
Total assets	$	108,546	$	107,916	$	630	$	—
Purchase consideration payable	$	24,003	$	—	$	—	$	24,003
Total liabilities	$	24,003	$	—	$	—	$	24,003

			Quoted Prices		Significant
			in Active		Other		Significant
			Markets for		Observable		Unobservable
	December 31,		Identical Items		Inputs		Inputs
Description	2013		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	34,178	$	34,178	$	—	$	—
Foreign currency forward contracts	208		—		208		—
Total assets	$	34,386	$	34,178	$	208	$	—
Purchase consideration payable	$	14,728	$	—	$	—	$	14,728
Total liabilities	$	14,728	$	—	$	—	$	14,728

The following table summarizes the basis used to measure the fair values of the Company’s financial instruments (amounts in thousands):

	Fair Value Measurements at Reporting Date, Using:
			Quoted Prices		Significant
			in Active		Other		Significant
			Markets for		Observable		Unobservable
	September 30,		Identical Items		Inputs		Inputs
Description	2014		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	131,466	$	131,466	$	—	$	—
Available-for-sale securities	12,458		—		—		12,458
Foreign currency forward contracts	279		—		279		—
Total assets	$	144,203	$	131,466	$	279	$	12,458
Purchase consideration payable	$	24,347	$	—	$	—	$	24,347
Total liabilities	$	24,347	$	—	$	—	$	24,347

			Quoted Prices		Significant
			in Active		Other		Significant
			Markets for		Observable		Unobservable
	December 31,		Identical Items		Inputs		Inputs
Description	2013		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	34,178	$	34,178	$	—	$	—
Foreign currency forward contracts	208		—		208		—
Total assets	$	34,386	$	34,178	$	208	$	—
Purchase consideration payable	$	14,728	$	—	$	—	$	14,728
Total liabilities	$	14,728	$	—	$	—	$	14,728

The following table summarizes the basis used to measure the fair values of the Company’s financial instruments (amounts in thousands):

			Fair Value Measurements at Reporting Date, Using:
			Quoted Prices		Significant
			in Active		Other		Significant
			Markets for		Observable		Unobservable
	March 31,		Identical Items		Inputs		Inputs
Description	2015		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	123,532	$	123,532	$	—	$	—
Available-for-sale securities	6,047		3,259		—		2,788
Total assets	$	129,579	$	126,791	$	—	$	2,788
Purchase consideration payable	$	12,443	$	—	$	—	$	12,443
Total liabilities	$	12,443	$	—	$	—	$	12,443

			Quoted Prices		Significant
			in Active		Other		Significant
			Markets for		Observable		Unobservable
	December 31,		Identical Items		Inputs		Inputs
Description	2014		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	70,679	$	70,679	$	—	$	—
Available-for-sale securities	8,391		—		—		8,391
Total assets	$	79,070	$	70,679	$	—	$	8,391
Purchase consideration payable	$	11,101	$	—	$	—	$	11,101
Total liabilities	$	11,101	$	—	$	—	$	11,101

The following table summarizes the basis used to measure the fair values of the Company’s financial instruments (amounts in thousands):

			Fair Value Measurements at Reporting Date, Using:
			Quoted Prices		Significant
			in Active		Other		Significant
			Markets for		Observable		Unobservable
	June 30,		Identical Items		Inputs		Inputs
Description	2015		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	257,090	$	257,090	$	—	$	—
Available-for-sale securities	6,173		4,991		—		1,182
Total assets	$	263,263	$	262,081	$	—	$	1,182
Purchase consideration payable	$	4,954	$	—	$	—	$	4,954
Total liabilities	$	4,954	$	—	$	—	$	4,954

			Quoted Prices		Significant
			in Active		Other		Significant
			Markets for		Observable		Unobservable
	December 31,		Identical Items		Inputs		Inputs
Description	2014		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	70,679	$	70,679	$	—	$	—
Available-for-sale securities	8,391		—		—		8,391
Total assets	$	79,070	$	70,679	$	—	$	8,391
Purchase consideration payable	$	11,101	$	—	$	—	$	11,101
Total liabilities	$	11,101	$	—	$	—	$	11,101

The following table summarizes the basis used to measure the fair values of the Company’s financial instruments (amounts in thousands):

			Fair Value Measurements at Reporting Date, Using:
			Quoted Prices		Significant
			in Active		Other		Significant
			Markets for		Observable		Unobservable
	September 30,		Identical Items		Inputs		Inputs
Description	2015		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	314,465	$	314,465	$	—	$	—
Available-for-sale securities	5,637		4,569		—		1,068
Total assets	$	320,102	$	319,034	$	—	$	1,068
Purchase consideration payable	$	4,961	$	—	$	—	$	4,961
Total liabilities	$	4,961	$	—	$	—	$	4,961

			Quoted Prices		Significant
			in Active		Other		Significant
			Markets for		Observable		Unobservable
	December 31,		Identical Items		Inputs		Inputs
Description	2014		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	70,679	$	70,679	$	—	$	—
Available-for-sale securities	8,391		—		—		8,391
Total assets	$	79,070	$	70,679	$	—	$	8,391
Purchase consideration payable	$	11,101	$	—	$	—	$	11,101
Total liabilities	$	11,101	$	—	$	—	$	11,101

Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]

The following table sets forth the components of the Company’s stock-based compensation expense for the three month periods ended March 31, 2014 and 2013 (in thousands):

	Three months ended March 31,
	2014	2013
Stock options and employee stock purchase plan	1,221	1,639
Restricted stock units	61	64
Total stock-based compensation expense	1,282	1,703

The following table sets forth the components of the Company’s stock-based compensation expense for the three and six month periods ended June 30, 2014 and 2013 (in thousands):

	Three months ended June 30,				Six months ended June 30,
	2014		2013		2014		2013
Stock options and employee stock purchase plan	$ 1,900	$	2,191	$	3,122	$	3,830
Restricted stock units	92		350		153		414
Total stock-based compensation expense	$ 1,992	$	2,541	$	3,275	$	4,244

The following table sets forth the components of the Company’s stock-based compensation expense for the three and nine month periods ended September 30, 2014 and 2013 (in thousands):

	Three months ended September 30,			Nine months ended September 30,
	2014		2013	2014	2013
Stock options and employee stock purchase plan	$	1,505	1,326	4,627	5,156
Restricted stock units	285		104	438	518
Total stock-based compensation expense	1,790		1,430	5,065	5,674

The following table sets forth the components of the Company’s stock-based compensation expense for the three month periods ended March 31, 2015 and 2014 (in thousands):

	Three months ended March 31,
	2015		2014
Stock options and employee stock purchase plan	$	2,252	$	1,221
Restricted stock units	722		61
Total stock-based compensation expense	$	2,974	$ 1,282

The following table sets forth the components of the Company’s stock-based compensation expense for the three and six month periods ended June 30, 2015 and 2014 (in thousands):

	Three months ended June 30,				Six months ended June 30,
	2015		2014		2015		2014
Stock options and employee stock purchase plan	$	2,415	$	1,900	$	4,667	$	3,122
Restricted stock units	742		92		1,464		153
Total stock-based compensation expense	$	3,157	$	1,992	$	6,131	$	3,275

The following table sets forth the components of the Company’s stock-based compensation expense for the three and nine month periods ended September 30, 2015 and 2014 (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2015		2014		2015		2014
Stock options and employee stock purchase plan	$	2,231	$	1,505	$	6,898	$	4,627
Restricted stock units	1,110		285		2,573		438
Total stock-based compensation expense	$	3,341	$	1,790	$	9,471	$	5,065

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	Three months ended March 31,
	2014	2013
Expected volatility	—	68		%
Expected life (in years)	—	4.0
Risk-free interest rate	—	0.84		%
Dividend yield	—	—
Fair value per stock option	—	$	6.56
Forfeiture rate	—	8		%

	Three months ended June 30,						Six months ended June 30,
	2014			2013			2014			2013
Expected volatility	54		%	58		%	54		%	59		%
Expected life (in years)	4.2			4.0			4.2			4.0
Risk-free interest rate	1.79		%	0.73		%	1.79		%	0.74		%
Dividend yield	—			—			—			—
Fair value per stock option	$	10.77		$	6.81		$	10.77		$	6.77
Forfeiture rate	8		%	8		%	8		%	8		%

	Three months ended September 30,				Nine months ended September 30,
	2014			2013	2014			2013
Expected volatility	70		%	N/A	58		%	59		%
Expected life (in years)	4.0			N/A	4.2			4.0
Risk-free interest rate	2.16		%	N/A	1.88		%	0.74		%
Dividend yield	—		%	N/A	—		%	—		%
Fair value per stock option	$	18.34		N/A	$	12.54		$	6.77
Forfeiture rate	8		%	N/A	8		%	8		%

	Three months ended March 31,
	2015			2014
Expected volatility	42		%	—
Expected life (in years)	4.75			—
Risk-free interest rate	1.56		%	—
Dividend yield	—			—
Fair value per stock option	$	18.21		—
Forfeiture rate	8		%	—

	Three months ended June 30,						Six months ended June 30,
	2015			2014			2015			2014
Expected volatility	44		%	54		%	43		%	54		%
Expected life (in years)	4.77			4.2			4.76			4.2
Risk-free interest rate	1.56		%	1.79		%	1.53		%	1.79		%
Dividend yield	—			—			—			—
Fair value per stock option	$	16.87		$	10.77		$	17.62		$	10.77
Forfeiture rate	8		%	8		%	8		%	8		%

	Three months ended September 30,						Nine months ended September 30,
	2015			2014			2015			2014
Expected volatility	43		%	70		%	43		%	58		%
Expected life (in years)	4.75			4.0			4.76			4.2
Risk-free interest rate	1.54		%	2.16		%	1.54		%	1.88		%
Dividend yield	—			—			—			—
Fair value per stock option	$	17.73		$	18.34		$	17.63		$	12.54
Forfeiture rate	8		%	8		%	8		%	8		%

Schedule of Share-based Compensation, Activity [Table Text Block]

The table below sets forth a summary of activity within the 2014 and 2003 Plans for the three months ended March 31, 2014:

	Number of Options (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands) (1)
Outstanding at December 31, 2013	9,228		$	4.45	1.61	$	186,169
Granted	—		—
Exercised	(56	)	3.54
Forfeited	(5	)	12.44
Outstanding at March 31, 2014	9,167		$	4.45	1.36	$	160,919
Exercisable at March 31, 2014	7,622		$	3.13	1.04	$	143,860

(1) May include value from potentially anti-dilutive options whose exercise price exceeds the closing stock price.

The table below sets forth a summary of activity within the 2014 and 2003 Plans for the six months ended June 30, 2014:

	Number of Options (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands) (1)
Outstanding at December 31, 2013	9,228		$	4.45	1.61	$	186,169
Granted	991		24.75
Exercised	(238	)	5.26
Forfeited	(19	)	15.48
Outstanding at June 30, 2014	9,962		$	6.42	2.75	$	267,200
Exercisable at June 30, 2014	8,136		$	3.47	2.24	$	242,324

(1) May include value from potentially anti-dilutive options whose exercise price exceeds the closing stock price.

The table below sets forth a summary of activity within the 2014 and 2003 Plans for the nine months ended September 30, 2014:

	Number of Options (in thousands)		Weighted  Average  Exercise Price		Weighted  Average  Remaining  Contractual  Term (Years)	Aggregate Intrinsic Value  (in thousands)  (1)
Outstanding at December 31, 2013	9,228		$	4.45	1.61	$	186,169
Granted	1,295		26.92
Exercised	(3,481	)	1.74
Forfeited	(43	)	19.66
Outstanding at September 30, 2014	6,999		$	9.86	3.02	$	184.869
Exercisable at September 30, 2014	4,998		$	4.92	1.97	$	156,650

(1) May include value from potentially anti-dilutive options whose exercise price exceeds the closing stock price.

The table below sets forth a summary of activity within the 2014 and 2003 Plans for the three months ended March 31, 2015:

	Number of Options (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands) (1)
Outstanding at December 31, 2014	6,386		$	11.44	2.48	$	158,097
Granted	297		48.05
Exercised	(2,222	)	4.17
Forfeited	(63	)	35.03
Outstanding at March 31, 2015	4,398		$	17.28	3.35	$	132,985
Exercisable at March 31, 2015	2,173		$	7.01	1.08	$	87,991

(1) May include value from potentially anti-dilutive options whose exercise price exceeds the closing stock price.

The table below sets forth a summary of activity within the 2014 and 2003 Plans for the six months ended June 30, 2015:

	Number of Options (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands) (1)
Outstanding at December 31, 2014	6,386		$	11.44	2.48	$	158,097
Granted	520		45.88
Exercised	(2,513	)	4.07
Forfeited	(81	)	33.16
Outstanding at June 30, 2015	4,312		$	19.50	3.49	$	104,178
Exercisable at June 30, 2015	2,277		$	10.07	1.55	$	76,480

(1) May include value from potentially anti-dilutive options whose exercise price exceeds the closing stock price.

The table below sets forth a summary of activity within the 2014 and 2003 Plans for the nine months ended September 30, 2015:

	Number of Options (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands) (1)
Outstanding at December 31, 2014	6,386		$	11.44	2.48	$	158,097
Granted	577		45.91
Exercised	(2,519	)	4.09
Forfeited	(106	)	34.30
Outstanding at September 30, 2015	4,338		$	19.75	3.31	$	38,007
Exercisable at September 30, 2015	2,419		$	10.88	1.62	$	42,636

(1) May include value from potentially anti-dilutive options whose exercise price exceeds the closing stock price.

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

	Number of Units	Weighted Average
	(in thousands)	Grant Date Fair Value
Non-vested at December 31, 2013	16	$	15.36
Granted	—	—
Forfeited	—	—
Vested	—	—
Non-vested at March 31, 2014	16	$	15.36

	Number of Units		Weighted Average
	(in thousands)		Grant Date Fair Value
Non-vested at December 31, 2013	16		$	15.36
Granted	72		24.74
Forfeited	—		—
Vested	(16	)	15.36
Non-vested at June 30, 2014	72		$	24.74

	Number of Units		Weighted Average
	(in thousands)		Grant Date Fair Value
Non-vested at December 31, 2013	16		$	15.36
Granted	337		27.54
Forfeited	—		—
Vested	(16	)	15.36
Non-vested at September 30, 2014	337		$	27.54

	Number of Units	Weighted Average
	(in thousands)	Grant Date Fair Value
Non-vested at December 31, 2014	337	$	35.31
Granted	—	—
Forfeited	—	—
Vested	—	—
Non-vested at March 31, 2015	337	$	35.31

	Number of Units		Weighted Average
	(in thousands)		Grant Date Fair Value
Non-vested at December 31, 2014	337		$	35.31
Granted	—		—
Forfeited	—		—
Vested	(18	)	24.74
Non-vested at June 30, 2015	319		$	35.90

	Number of Units		Weighted Average
	(in thousands)		Grant Date Fair Value
Non-vested at December 31, 2014	337		$	35.31
Granted	—		—
Forfeited	—		—
Vested (1)	(84	)	35.31
Non-vested at September 30, 2015	253		$	35.31

(1) As a result of the delay in filing the 2015 financials, approximately 66,000 units of vested restricted stock has not yet been released to grantees as of and for the year to date period ended September 30, 2015.

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]

Net trade accounts receivable consists of the following (in thousands):

	MARCH 31,			DECEMBER 31,
	2014			2013
Gross accounts receivable	$	93,201		$	88,165
Less reserves for:
Chargebacks and rebates	(18,095		)	(12,882		)
Product returns	(7,378		)	(8,164		)
Discounts and allowances	(1,798		)	(1,644		)
Advertising and promotions	(391		)	(452		)
Doubtful accounts	(39		)	(25		)
Trade accounts receivable, net	$	65,500		$	64,998

Net trade accounts receivable consists of the following (in thousands):

	JUNE 30,
	2014 (As restated)			DECEMBER 31, 2013
Gross accounts receivable	$	213,392		$	88,165
Less reserves for:
Chargebacks and rebates	(58,312		)	(12,882		)
Product returns	(20,492		)	(8,164		)
Discounts and allowances	(5,155		)	(1,644		)
Advertising and promotions	(566		)	(452		)
Doubtful accounts	(93		)	(25		)
Trade accounts receivable, net	$	128,774		$	64,998

Net trade accounts receivable consists of the following (in thousands):

	SEPTEMBER 30,
	2014 (As restated)			DECEMBER 31, 2013
Gross accounts receivable	$	293,113		$	88,165
Less reserves for:
Chargebacks and rebates	(116,997		)	(12,882		)
Product returns	(38,266		)	(8,164		)
Discounts and allowances	(8,753		)	(1,644		)
Advertising and promotions	(1,031		)	(452		)
Doubtful accounts	(94		)	(25		)
Trade accounts receivable, net	$	127,972		$	64,998

Net trade accounts receivable consists of the following (in thousands):

				DECEMBER 31,
	MARCH 31, 2015			2014 (as Restated)
Gross accounts receivable	$	414,757		$	446,925
Less reserves for:
Chargebacks and rebates	(162,249		)	(198,112		)
Product returns	(47,578		)	(44,646		)
Discounts and allowances	(13,503		)	(15,554		)
Advertising and promotions	(440		)	(758		)
Doubtful accounts	(277		)	(309		)
Trade accounts receivable, net	$	190,710		$	187,545

Net trade accounts receivable consists of the following (in thousands):

				DECEMBER 31,
	JUNE 30, 2015			2014 (as Restated)
Gross accounts receivable	$	392,015		$	446,925
Less reserves for:
Chargebacks and rebates	(193,683		)	(198,112		)
Product returns	(51,195		)	(44,646		)
Discounts and allowances	(14,801		)	(15,554		)
Advertising and promotions	(924		)	(758		)
Doubtful accounts	(600		)	(309		)
Trade accounts receivable, net	$	130,812		$	187,545

Net trade accounts receivable consists of the following (in thousands):

				DECEMBER 31,
	SEPTEMBER 30, 2015			2014 (as Restated)
Gross accounts receivable	$	426,002		$	446,925
Less reserves for:
Chargebacks and rebates	(217,602		)	(198,112		)
Product returns	(53,910		)	(44,646		)
Discounts and allowances	(13,420		)	(15,554		)
Advertising and promotions	(826		)	(758		)
Doubtful accounts	(1,324		)	(309		)
Trade accounts receivable, net	$	138,920		$	187,545

Schedule Of Adjustments To Gross Sales [Table Text Block]

For the three month periods ended March 31, 2014 and 2013, the Company recorded the following adjustments to gross sales (in thousands):

	Three Months Ended March 31,
	2014			2013
Gross sales	$	149,300		$	123,818
Less adjustments for:
Chargebacks and rebates	(51,873		)	(43,763		)
Product returns	(886		)	(1,231		)
Discounts and allowances	(2,435		)	(1,975		)
Administrative fees	(2,152		)	(1,963		)
Advertising, promotions and others	(1,332		)	(1,032		)
Revenues, net	$	90,622		$	73,854

For the three and six month periods ended June 30, 2014 and 2013, the Company recorded the following adjustments to gross sales (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2014 (As restated)			2013			2014 (As restated)			2013
Gross sales	$	278,219		$	126,113		$	427,519		$	249,930
Less adjustments for:
Chargebacks and rebates	(132,854		)	(42,966		)	(184,727		)	(86,729		)
Product returns	(88		)	(482		)	(974		)	(1,713		)
Discounts and allowances	(5,462		)	(1,947		)	(7,897		)	(3,922		)
Administrative fees	(3,354		)	(2,358		)	(5,506		)	(4,320		)
Advertising, promotions and others	(2,589		)	(1,348		)	(3,921		)	(2,380		)
Revenues, net	$	133,872		$	77,012		$	224,494		$	150,866

For the three and nine month periods ended September 30, 2014 and 2013, the Company recorded the following adjustments to gross sales (in thousands):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2014 (As restated)			2013			2014 (As restated)			2013
Gross sales	$	397,422		$	137,235		$	824,941		$	387,165
Less adjustments for:
Chargebacks and rebates	(244,288		)	(49,373		)	(429,014		)	(136,102		)
Product returns	(8,958		)	(719		)	(9,932		)	(2,432		)
Discounts and allowances	(8,933		)	(2,228		)	(16,830		)	(6,150		)
Administrative fees	(6,435		)	(2,035		)	(11,942		)	(6,355		)
Advertising, promotions and others	(1,110		)	(988		)	(5,031		)	(3,368		)
Revenues, net	$	127,698		$	81,892		$	352,192		$	232,758

For the three month periods ended March 31, 2015 and 2014, the Company recorded the following adjustments to gross sales (in thousands):

	Three Months Ended March 31,
	2015			2014
Gross sales	$	568,016		$	149,300
Less adjustments for:
Chargebacks and rebates	(293,181		)	(51,873		)
Product returns	(5,574		)	(886		)
Discounts and allowances	(14,044		)	(2,435		)
Administrative fees	(26,123		)	(2,152		)
Advertising, promotions and others	(1,716		)	(1,332		)
Revenues, net	$	227,378		$	90,622

For the three and six month periods ended June 30, 2015 and 2014, the Company recorded the following adjustments to gross sales (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2015			2014 (As restated)			2015			2014 (as Restated)
Gross sales	$	607,307		$	278,219		$	1,175,324		$	427,519
Less adjustments for:
Chargebacks and rebates	(363,008		)	(132,854		)	(656,189		)	(184,727		)
Product returns	(5,896		)	(88		)	(11,470		)	(974		)
Discounts and allowances	(11,622		)	(5,462		)	(25,666		)	(7,897		)
Administrative fees	(3,786		)	(3,354		)	(29,910		)	(5,506		)
Advertising, promotions and others	(2,075		)	(2,589		)	(3,791		)	(3,921		)
Revenues, net	$	220,920		$	133,872		$	448,298		$	224,494

For the three and nine month periods ended September 30, 2015 and 2014, the Company recorded the following adjustments to gross sales (in thousands):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014 (As restated)			2015			2014 (as Restated)
Gross sales	$	633,634		$	397,422		$	1,808,958		$	824,941
Less adjustments for:
Chargebacks and rebates	(331,771		)	(244,288		)	(987,960		)	(429,014		)
Product returns	(7,683		)	(8,958		)	(19,154		)	(9,932		)
Discounts and allowances	(11,744		)	(8,933		)	(37,410		)	(16,830		)
Administrative fees	(23,598		)	(6,435		)	(53,508		)	(11,942		)
Advertising, promotions and others	(2,037		)	(1,110		)	(5,827		)	(5,031		)
Revenues, net	$	256,801		$	127,698		$	705,099		$	352,192

Schedule of Inventory, Current [Table Text Block]

The components of inventories are as follows (in thousands):

	MARCH 31, 2014		DECEMBER 31, 2013
Finished goods	$	21,639	$	22,886
Work in process	3,539		3,883
Raw materials and supplies	36,835		29,213
Inventories, net	$	62,013	$	55,982

The components of inventories are as follows (in thousands):

	JUNE 30, 2014 (as Restated)		DECEMBER 31, 2013
Finished goods	$	49,349	$	22,886
Work in process	5,074		3,883
Raw materials and supplies	59,243		29,213
Inventories, net	$	113,666	$	55,982

The components of inventories are as follows (in thousands):

	SEPTEMBER 30, 2014 (as Restated)		DECEMBER 31, 2013
Finished goods	$	66,598	$	22,886
Work in process	4,574		3,883
Raw materials and supplies	60,944		29,213
Inventories, net	$	132,116	$	55,982

The components of inventories are as follows (in thousands):

	MARCH 31, 2015		DECEMBER 31, 2014 (as Restated)
Finished goods	$	76,194	$	69,499
Work in process	10,032		4,075
Raw materials and supplies	63,177		61,623
Inventories, net	$	149,403	$	135,197

The components of inventories are as follows (in thousands):

	JUNE 30, 2015		DECEMBER 31, 2014 (as Restated)
Finished goods	$	74,272	$	69,499
Work in process	8,628		4,075
Raw materials and supplies	73,416		61,623
Inventories, net	$	156,315	$	135,197

The components of inventories are as follows (in thousands):

	SEPTEMBER 30, 2015		DECEMBER 31, 2014 (as Restated)
Finished goods	$	79,583	$	69,499
Work in process	10,309		4,075
Raw materials and supplies	85,959		61,623
Inventories, net	$	175,851	$	135,197

Property, Plant and Equipment [Table Text Block]

Property, plant and equipment consist of the following (in thousands):

	MARCH 31, 2014			DECEMBER 31, 2013
Land and land improvements	$	2,686		$	2,606
Buildings and leasehold improvements	48,653			46,281
Furniture and equipment	78,153			76,536
Sub-total	129,492			125,423
Accumulated depreciation	(56,455		)	(54,470		)
Property, plant and equipment placed in service, net	73,037			70,953
Construction in progress	14,638			11,155
Property, plant and equipment, net	$	87,675		$	82,108

Property, plant and equipment consist of the following (in thousands):

	JUNE 30, 2014 (as Restated)			DECEMBER 31, 2013
Land and land improvements	$	8,678		$	2,606
Buildings and leasehold improvements	60,474			46,281
Furniture and equipment	109,531			76,536
Sub-total	178,683			125,423
Accumulated depreciation	(60,027		)	(54,470		)
Property, plant and equipment placed in service, net	118,656			70,953
Construction in progress	16,808			11,155
Property, plant and equipment, net	$	135,464		$	82,108

Property, plant and equipment consist of the following (in thousands):

	SEPTEMBER 30, 2014 (as Restated)			DECEMBER 31, 2013
Land and land improvements	$	9,395		$	2,606
Buildings and leasehold improvements	61,468			46,281
Furniture and equipment	112,127			76,536
Sub-total	182,990			125,423
Accumulated depreciation	(64,829		)	(54,470		)
Property, plant and equipment placed in service, net	118,161			70,953
Construction in progress	21,213			11,155
Property, plant and equipment, net	$	139,374		$	82,108

Property, plant and equipment consist of the following (in thousands):

	MARCH 31, 2015			DECEMBER 31, 2014 (as Restated)
Land and land improvements	$	17,721		$	9,323
Buildings and leasehold improvements	79,216			63,846
Furniture and equipment	123,748			112,552
Sub-total	220,685			185,721
Accumulated depreciation	(72,756		)	(67,937		)
Property, plant and equipment placed in service, net	147,929			117,784
Construction in progress	28,062			26,412
Property, plant and equipment, net	$	175,991		$	144,196

Property, plant and equipment consist of the following (in thousands):

	JUNE 30, 2015			DECEMBER 31, 2014 (as Restated)
Land and land improvements	$	17,762		$	9,323
Buildings and leasehold improvements	79,954			63,846
Furniture and equipment	132,235			112,552
Sub-total	229,951			185,721
Accumulated depreciation	(76,589		)	(67,937		)
Property, plant and equipment placed in service, net	153,362			117,784
Construction in progress	25,877			26,412
Property, plant and equipment, net	$	179,239		$	144,196

Property, plant and equipment consist of the following (in thousands):

	SEPTEMBER 30, 2015			DECEMBER 31, 2014 (as Restated)
Land and land improvements	$	17,351		$	9,323
Buildings and leasehold improvements	84,767			63,846
Furniture and equipment	137,129			112,552
Sub-total	239,247			185,721
Accumulated depreciation	(81,467		)	(67,937		)
Property, plant and equipment placed in service, net	157,780			117,784
Construction in progress	19,653			26,412
Property, plant and equipment, net	$	177,433		$	144,196

Schedule of Goodwill [Table Text Block]

The following table provides a summary of the activity in goodwill by segment for the three months ended March 31, 2014 (in thousands):

	Consumer Health		Prescription Pharmaceuticals		Total
Balances at December 31, 2013	$	11,863	$	17,968	$	29,831
Currency translation adjustments	—		606		606
Balances at March 31, 2014	$	11,863	$	18,574	$	30,437

The following table provides a summary of the activity in goodwill by segment for the six months ended June 30, 2014 (in thousands):

	Consumer Health		Prescription Pharmaceuticals			Total
Balances at December 31, 2013	$	11,863	$	17,968		$	29,831
Currency translation adjustments	—		549			549
Acquisitions	4,854		166,415			171,269
Dispositions	—		(15,284		)	(15,284		)
Balances at June 30, 2014 (as Restated)	$	16,717	$	169,648		$	186,365

The following table provides a summary of the activity in goodwill by segment for the nine months ended September 30, 2014 (in thousands):

	Consumer Health		Prescription  Pharmaceuticals			Total
Balances at December 31, 2013	$	11,863	$	17,968		$	29,831
Currency translation adjustments	—		85			85
Acquisitions	4,854		266,395			271,249
Dispositions	—		(15,284		)	(15,284		)
Balances at September 30, 2014 (as Restated)	$	16,717	$	269,164		$	285,881

The following table provides a summary of the activity in goodwill by segment for the three months ended March 31, 2015 (in thousands):

	Consumer Health		Prescription Pharmaceuticals		Total
Balances at December 31, 2014 (as Restated)	$	16,717	$	268,566	$	285,283
Currency translation adjustments	—		391		391
Acquisitions	—		—		—
Dispositions	—		—		—
Balances at March 31, 2015	$	16,717	$	268,957	$	285,674

The following table provides a summary of the activity in goodwill by segment for the six months ended June 30, 2015 (in thousands):

	Consumer Health		Prescription Pharmaceuticals		Total
Balances at December 31, 2014 (as Restated)	$	16,717	$	268,566	$	285,283
Currency translation adjustments	—		73		73
Acquisitions	—		—		—
Dispositions	—		—		—
Balances at June 30, 2015	$	16,717	$	268,639	$	285,356

The following table provides a summary of the activity in goodwill by segment for the nine months ended September 30, 2015 (in thousands):

	Consumer Health		Prescription Pharmaceuticals			Total
Balances at December 31, 2014 (as Restated)	$	16,717	$	268,566		$	285,283
Currency translation adjustments	—		(575		)	(575		)
Acquisitions	—		—			—
Dispositions	—		—			—
Balances at September 30, 2015	$	16,717	$	267,991		$	284,708

Schedule of Finite-Lived Intangible Assets [Table Text Block]

The following table sets forth information about the net book value of the Company’s other intangible assets as of March 31, 2014 and December 31, 2013, and the weighted average remaining amortization period as of March 31, 2014 and December 31, 2013 (dollar amounts in thousands):

	Gross Amount		Accumulated Amortization			Impairment		Net Balance		Wgtd Avg Remaining Amortization Period
March 31, 2014
Product licensing rights	$	162,887	$	(39,954	)	$	—	$	122,933	10.0
Trademarks	9,500		(924		)	—		8,576		27.2
Customer relationships	6,243		(1,736		)	—		4,507		9.6
Non-compete agreement	2,510		(1,310		)	—		1,200		1.9
	$	181,140	$	(43,924	)	$	—	$	137,216
DECEMBER 31, 2013
Product licensing rights	$	151,504	$	(35,604	)	—		$	115,900	9.8
Trademarks	9,500		(844		)	—		8,656		27.4
Customer relationships	6,166		(1,528		)	—		4,638		9.8
Non-compete agreement	2,428		(1,117		)	—		1,311		2.2
	$	169,598	$	(39,093	)	—		130,505

The following table sets forth information about the net book value of the Company’s other intangible assets as of June 30, 2014 and December 31, 2013, and the weighted average remaining amortization period as of June 30, 2014 and December 31, 2013 (dollar amounts in thousands):

	Gross Amount		Accumulated Amortization			Impairment		Net Balance		Wgtd Avg Remaining Amortization Period
JUNE 30, 2014 (as Restated)
Product licensing rights	$	476,659	$	(46,871	)	$	—	$	429,788	13.8
IPR&D	9,400		—			—		9,400		N/A - Indefinite lived
Trademarks	15,000		(1,128		)	—		13,872		19.9
Customer relationships	6,561		(2,002		)	—		4,559		9.0
Other Intangibles	6,000		(68		)	—		5,932		4.8
Non-compete agreement	2,552		(1,512		)	—		1,040		1.7
	$	516,172	$	(51,581	)	$	—	$	464,591
DECEMBER 31, 2013
Product licensing rights	$	151,504	$	(35,604	)	—		$	115,900	9.8
IPR&D	—		—			—		—		N/A - Indefinite lived
Trademarks	9,500		(844		)	—		8,656		27.4
Customer relationships	6,166		(1,528		)	—		4,638		9.8
Other Intangibles	—		—			—		—		—
Non-compete agreement	2,428		(1,117		)	—		1,311		2.2
	$	169,598	$	(39,093	)	—		130,505

The following table sets forth information about the net book value of the Company’s other intangible assets as of September 30, 2014 and December 31, 2013, and the weighted average remaining amortization period as of September 30, 2014 and December 31, 2013 (dollar amounts in thousands):

	Gross Amount		Accumulated  Amortization			Impairment		Net Balance		Wgtd Avg Remaining  Amortization Period
SEPTEMBER 30, 2014 (as Restated)
Product licensing rights	$	729,628	$	(58,501	)	$	—	$	671,127	12.6
IPR&D	221,771		—			—		221,771		N/A - Indefinite lived
Trademarks	16,000		(1,406		)	—		14,594		18.6
Customer relationships	6,502		(3,327		)	—		3,175		11.0
Other Intangibles	11,200		(445		)	—		10,755		7.6
Non-compete agreement	2,490		(1,629		)	—		861		1.4
	$	987,591	$	(65,308	)	$	—	$	922,283
DECEMBER 31, 2013
Product licensing rights	$	151,504	$	(35,604	)	—		$	115,900	9.8
IPR&D	—		—			—		—		N/A - Indefinite lived
Trademarks	9,500		(844		)	—		8,656		27.4
Customer relationships	6,166		(1,528		)	—		4,638		9.8
Other Intangibles	—		—			—		—		—
Non-compete agreement	2,428		(1,117		)	—		1,311		2.2
	$	169,598	$	(39,093	)	—		$ 130,505

The following table sets forth information about the net book value of the Company’s other intangible assets as of March 31, 2015 and December 31, 2014, and the weighted average remaining amortization period as of March 31, 2015 and December 31, 2014 (dollar amounts in thousands):

	Gross Amount		Accumulated Amortization			Impairment		Net Balance		Wgtd Avg Remaining Amortization Period
MARCH 31, 2015
Product licensing rights	$	778,734	$	(89,244	)	$	—	$	689,490	13.9
IPR&D	227,259		—			—		227,259		N/A - Indefinite lived
Trademarks	16,000		(2,036		)	—		13,964		22.6
Customer relationships	6,464		(3,569		)	—		2,895		12.5
Other Intangibles	11,234		(1,309		)	—		9,925		8.7
Non-compete agreement	2,449		(1,902		)	—		547		0.8
	$	1,042,140	$	(98,060	)	$	—	$	944,080
DECEMBER 31, 2014 (as Restated)
Product licensing rights	$	778,734	$	(73,943	)	$	—	$	704,791	12.1
IPR&D	227,259		—			—		227,259		N/A - Indefinite lived
Trademarks	16,000		(1,721		)	—		14,279		18.6
Customer relationships	6,502		(3,467		)	—		3,035		11.0
Other Intangibles	11,235		(879		)	—		10,356		7.5
Non-compete agreement	2,333		(1,650		)	—		683		1.4
	$	1,042,063	$	(81,660	)	$	—	$	960,403

The following table sets forth information about the net book value of the Company’s other intangible assets as of June 30, 2015 and December 31, 2014, and the weighted average remaining amortization period as of June 30, 2015 and December 31, 2014 (dollar amounts in thousands):

	Gross Amount		Accumulated Amortization			Impairment			Net Balance		Wgtd Avg Remaining Amortization Period
JUNE 30, 2015
Product licensing rights	$	779,234	$	(104,547	)	$	—		$	674,687	13.7
IPR&D	227,559		—			(2,627		)	224,932		N/A - Indefinite lived
Trademarks	16,000		(2,352		)	—			13,648		22.3
Customer relationships	6,424		(3,607		)	—			2,817		12.2
Other Intangibles	11,234		(1,739		)	—			9,495		8.4
Non-compete agreement	2,406		(2,015		)	—			391		0.5
	$	1,042,857	$	(114,260	)	$	(2,627	)	$	925,970
DECEMBER 31, 2014 (as Restated)
Product licensing rights	$	778,734	$	(73,943	)	$	—		$	704,791	12.1
IPR&D	227,259		—			—			227,259		N/A - Indefinite lived
Trademarks	16,000		(1,721		)	—			14,279		18.6
Customer relationships	6,502		(3,467		)	—			3,035		11.0
Other Intangibles	11,235		(879		)	—			10,356		7.5
Non-compete agreement	2,333		(1,650		)	—			683		1.4
	$	1,042,063	$	(81,660	)	$	—		$	960,403

The following table sets forth information about the net book value of the Company’s other intangible assets as of September 30, 2015 and December 31, 2014, and the weighted average remaining amortization period as of September 30, 2015 and December 31, 2014 (dollar amounts in thousands):

	Gross Amount		Accumulated Amortization			Impairment			Reclass- ifications (1)			Net Balance		Wgtd Avg Remaining Amortization Period
SEPTEMBER 30, 2015
Product licensing rights	$	781,569	$	(120,126	)	$	—		$	38,000		$	699,443	13.4
IPR&D	227,559		—			(2,627		)	(38,000		)	186,932		N/A - Indefinite lived
Trademarks	16,000		(2,667		)	—			—			13,333		22.1
Customer relationships	6,342		(3,590		)	—			—			2,752		12.0
Other Intangibles	11,234		(2,170		)	—			—			9,064		8.2
Non-compete agreement	2,431		(2,153		)	—			—			279		0.3
	$	1,045,136	$	(130,706	)	$	(2,627	)	$	—		$	911,803
DECEMBER 31, 2014 (as Restated)
Product licensing rights	$	778,734	$	(73,943	)	$	—		$	—		$	704,791	12.1
IPR&D	227,259		—			—			—			227,259		N/A - Indefinite lived
Trademarks	16,000		(1,721		)	—			—			14,279		18.6
Customer relationships	6,502		(3,467		)	—			—			3,035		11.0
Other Intangibles	11,235		(879		)	—			—			10,356		7.5
Non-compete agreement	2,333		(1,650		)	—			—			683		1.4
	$	1,042,063	$	(81,660	)	$	—		$	—		$	960,403

(1) This amount reclassifies the acquisition date value of one previously IPR&D asset due to launch in the nine month period ended September 30,2015.

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

Information about the computation of basic and diluted earnings per share is detailed below (in thousands, except per share data):

	Three Months Ended March 31,
	2014 (as Restated)		2013
Income (loss) from continuing operations used for basic earnings per share	$	9,494	$	10,842
Convertible debt income adjustments, net of tax	—		—
Income (loss) from continuing operations adjusted for convertible debt as used for diluted earnings per share	$	9,494	$	10,842
Income (loss) from continuing operations per share:
Basic	$	0.10	$	0.11
Diluted	$	0.08	$	0.10
Shares used in computing net income (loss) per share:
Weighted average basic shares outstanding	96,633		95,926
Dilutive securities:
Stock option and unvested RSUs	4,845		4,193
Stock warrants	6,843		6,589
Shares issuable upon conversion of convertible notes (1)	8,563		4,843
Total dilutive securities	20,251		15,625
Weighted average diluted shares outstanding	116,884		111,551
Shares subject to stock options omitted from the calculation of income per share as their effect would have been anti-dilutive	50		1,496

(1) As of the period ended March 31, 2014 the number of shares issuable upon conversion of the Notes is based on the assumption that the Company would repay the principal of the Notes in cash and pay any incremental value in shares of common stock.

  Information about the computation of basic and diluted earnings per share is detailed below (in thousands, except per share data):

	Three Months Ended June 30,					Six Months Ended June 30,
	2014 (as Restated) (1)			2013		2014 (as Restated)			2013
Income (loss) from continuing operations used for basic earnings per share	$	(752	)	$	12,637	$	8,742		$	23,479
Convertible debt income adjustments, net of tax	—			—		—			—
Income (loss) from continuing operations adjusted for convertible debt as used for diluted earnings per share	$	(752	)	$	12,637	$	8,742		$	23,479
Income (loss) from continuing operations per share:
Basic	$	(0.01	)	$	0.13	$	0.09		$	0.24
Diluted	$	(0.01	)	$	0.11	$	0.07		$	0.21
(Loss) from discontinued operations, net of tax	$	(504	)	$	—	$	(504	)	$	—
(Loss) from discontinued operations per share:
Basic	$	—		$	—	$	(0.01	)	$	—
Diluted	$	—		$	—	$	—		$	—
Shares used in computing net income (loss) per share:
Weighted average basic shares outstanding	103,183			96,122		99,926			96,025
Dilutive securities:
Stock option and unvested RSUs	—			4,380		5,008			4,383
Stock warrants	—			6,614		3,779			6,564
Shares issuable upon conversion of convertible notes (2)	—			5,212		8,863			5,038
Total dilutive securities	—			16,206		17,650			15,985
Weighted average diluted shares outstanding	103,183			112,328		117,576			112,010
Shares subject to stock options omitted from the calculation of income per share as their effect would have been anti-dilutive	—			1,373		336			1,289

(1) As a result of the loss from continuing operations in the three months ended June 30, 2014, the effect of potentially dilutive securities would be anti-dilutive and have been omitted from the calculation of diluted earnings per share consistent with GAAP.

(2) As of the period ended June 30, 2014 the number of shares issuable upon conversion of the Notes is based on the assumption that the Company would repay the principal of the Notes in cash and pay any incremental value in shares of common stock.

  Information about the computation of basic and diluted earnings per share is detailed below (in thousands, except per share data):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2014 (as Restated) (1)			2013		2014 (as Restated) (1)			2013
Income (loss) from continuing operations used for basic earnings per share	$	(12,333	)	$	12,205	$	(3,591	)	$	35,684
Convertible debt income adjustments, net of tax	—			—		—			—
Income (loss) from continuing operations adjusted for convertible debt as used for diluted earnings per share	$	(12,333	)	$	12,205	$	(3,591	)	$	35,684
Income (loss) from continuing operations per share:
Basic	$	(0.12	)	$	0.13	$	(0.04	)	$	0.37
Diluted	$	(0.12	)	$	0.11	$	(0.04	)	$	0.32
(Loss) from discontinued operations, net of tax	$	—		$	—	$	(504	)	$	—
(Loss) from discontinued operations per share:
Basic	$	—		$	—	$	—		$	—
Diluted	$	—		$	—	$	—		$	—
Shares used in computing net income (loss) per share:
Weighted average basic shares outstanding	105,438			96,238		101,784			96,096
Dilutive securities:
Stock option and unvested RSUs	—			4,510		—			4,408
Stock warrants	—			6,687		—			6,635
Shares issuable upon conversion of convertible notes (2)	—			6,282		—			5,505
Total dilutive securities	—			17,479		—			16,548
Weighted average diluted shares outstanding	105,438			113,717		101,784			112,644
Shares subject to stock options omitted from the calculation of income per share as their effect would have been anti-dilutive	—			1,110		—			1,335

(1) As a result of the loss from continuing operations in the three and nine months ended September 30, 2014, the effect of potentially dilutive securities would be anti-dilutive and have been omitted from the calculation of diluted earnings per share consistent with GAAP.

(2) As of the period ended September 30, 2014 the number of shares issuable upon conversion of the Notes is based on the assumption that the Company would repay the principal of the Notes in cash and pay any incremental value in shares of common stock.

 Information about the computation of basic and diluted earnings per share is detailed below (in thousands, except per share data):

	Three Months Ended March 31,
	2015		2014
Income from continuing operations used for basic earnings per share	$	37,538	$	9,494
Convertible debt income adjustments, net of tax (1)	1,107		—
Income from continuing operations adjusted for convertible debt as used for diluted earnings per share	$	38,645	$	9,494
Income from continuing operations per share:
Basic	$	0.33	$	0.10
Diluted	$	0.31	$	0.08
Shares used in computing net income (loss) per share:
Weighted average basic shares outstanding	113,352		96,633
Dilutive securities:
Stock option and unvested RSUs	2,085		4,845
Stock warrants	—		6,843
Shares issuable upon conversion of convertible notes (1)	9,940		8,563
Total dilutive securities	12,025		20,251
Weighted average diluted shares outstanding	125,377		116,884
Shares subject to stock options omitted from the calculation of income per share as their effect would have been anti-dilutive	575		50

(1) As of the period ended March 31, 2014 the number of shares issuable upon conversion of the Notes is based on the assumption that the Company would repay the principal of the Notes in cash and pay any incremental value in shares of common stock. Due to a change in the expectation that management may settle all future note conversions solely through shares in the quarter ended December 31, 2014, the diluted income from continuing operations per share calculation includes the dilutive effect of convertible debt and is offset by the exclusion of interest expense and deferred financing fees related to the convertible debt of $1.1 million, after-tax for the quarter ended March 31, 2015. This also alters the dilutive share effect of the convertible notes as the Company is now using the if-converted method for debt conversion obligations.

  Information about the computation of basic and diluted earnings per share is detailed below (in thousands, except per share data):

	Three Months Ended June 30,					Six Months Ended June 30,
	2015		2014 (as Restated) (1)			2015		2014 (as Restated)
Income from continuing operations used for basic earnings per share	$	32,508	$	(752	)	$	70,046	$	8,742
Convertible debt income adjustments, net of tax (2)	927		—			2,034		—
Income from continuing operations adjusted for convertible debt as used for diluted earnings per share	$	33,435	$	(752	)	$	72,080	$	8,742
Income from continuing operations per share:
Basic	$	0.28	$	(0.01	)	$	0.61	$	0.09
Diluted	$	0.27	$	(0.01	)	$	0.57	$	0.07
(Loss) from discontinued operations, net of tax	$	—	$	(504	)	$	—	$	(504	)
(Loss) from discontinued operations per share:
Basic	$	—	$	—		$	—	$	(0.01	)
Diluted	$	—	$	—		$	—	$	—
Shares used in computing net income (loss) per share:
Weighted average basic shares outstanding	115,808		103,183			114,587		99,926
Dilutive securities:
Stock option and unvested RSUs	1,655		—			1,869		5,008
Stock warrants	—		—			—		3,779
Shares issuable upon conversion of convertible notes (2)	8,456		—			9,194		8,863
Total dilutive securities	10,111		—			11,063		17,650
Weighted average diluted shares outstanding	125,919		103,183			125,650		117,576
Shares subject to stock options omitted from the calculation of income per share as their effect would have been anti-dilutive	874		—			724		336

(1) As a result of the loss from continuing operations in the three months ended June 30, 2014, the effect of potentially dilutive securities would be anti-dilutive and have been omitted from the calculation of diluted earnings per share consistent with GAAP.

(2) As of the three and six month period ended June 30, 2014 the number of shares issuable upon conversion of the Notes is based on the assumption that the Company would repay the principal of the Notes in cash and pay any incremental value in shares of common stock. Due to a change in the expectation that management may settle all future note conversions solely through shares in the quarter ended December 31, 2014, the diluted income from continuing operations per share calculation includes the dilutive effect of convertible debt and is offset by the exclusion of interest expense and deferred financing fees related to the convertible debt of $0.9 million, after-tax and $2.0 million, after-tax for the three and six month periods ended June 30, 2015. This also alters the dilutive share effect of the convertible notes as the Company is now using the if-converted method for debt conversion obligations.

  Information about the computation of basic and diluted earnings per share is detailed below (in thousands, except per share data):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2015		2014 (as Restated) (1)			2015		2014 (as Restated) (1)
Income from continuing operations used for basic earnings per share	$	47,967	$	(12,333	)	$	118,013	$	(3,591	)
Convertible debt income adjustments, net of tax (2)	580		—			2,614		—
Income from continuing operations adjusted for convertible debt as used for diluted earnings per share	$	48,547	$	(12,333	)	$	120,627	$	(3,591	)
Income from continuing operations per share:
Basic	$	0.40	$	(0.12	)	$	1.02	$	(0.04	)
Diluted	$	0.39	$	(0.12	)	$	0.96	$	(0.04	)
(Loss) from discontinued operations, net of tax	$	—	$	—		$	—	$	(504	)
(Loss) from discontinued operations per share:
Basic	$	—	$	—		$	—	$	—
Diluted	$	—	$	—		$	—	$	—
Shares used in computing net income (loss) per share:
Weighted average basic shares outstanding	119,260		105,438			116,162		101,784
Dilutive securities:
Stock option and unvested RSUs	1,529		—			1,761		—
Stock warrants	—		—			—		—
Shares issuable upon conversion of convertible notes (2)	5,102		—			7,815		—
Total dilutive securities	6,631		—			9,576		—
Weighted average diluted shares outstanding	125,891		105,438			125,738		101,784
Shares subject to stock options omitted from the calculation of income per share as their effect would have been anti-dilutive	973		—			809		—

(1) As a result of the loss from continuing operations in the three and nine months ended September 30, 2014, the effect of potentially dilutive securities would be anti-dilutive and have been omitted from the calculation of diluted earnings per share consistent with GAAP.

(2) As of the three and nine month period ended September 30, 2014 the number of shares issuable upon conversion of the Notes is based on the assumption that the Company would repay the principal of the Notes in cash and pay any incremental value in shares of common stock. Due to a change in the expectation that management may settle all future note conversions solely through shares in the quarter ended December 31, 2014, the diluted income from continuing operations per share calculation includes the dilutive effect of convertible debt and is offset by the exclusion of interest expense and deferred financing fees related to the convertible debt of $0.6 million, after-tax and $2.6 million, after-tax for the three and nine month periods ended September 30, 2015. This also alters the dilutive share effect of the convertible notes as the Company is now using the if-converted method for debt conversion obligations.

Schedules of Concentration of Risk, by Risk Factor [Table Text Block]

	Three months ended March 31,
Big 3 Wholesalers combined:	2014		2013
Percentage of gross sales	62	%	59	%
Percentage of net sales revenues	45	%	42	%

	March 31, 2014		December 31, 2013
Percentage of gross trade accounts receivable	69	%	63	%

	Three months ended June 30,				Six months ended June 30,
Big 3 Wholesalers combined:	2014 (as Restated)		2013		2014 (as Restated)		2013
Percentage of gross sales	69	%	57	%	67	%	58	%
Percentage of net sales revenues	49	%	38	%	47	%	40	%

	June 30, 2014 (as Restated)		December 31, 2013
Percentage of gross trade accounts receivable	73	%	63	%

	Three months ended September 30,				Nine months ended September 30,
Big 3 Wholesalers combined:	2014 (as Restated)		2013		2014 (as Restated)		2013
Percentage of gross sales	79	%	61	%	73	%	59	%
Percentage of net sales revenues	43	%	41	%	46	%	41	%

	September 30,  2014 (as Restated)		December 31,  2013
Percentage of gross trade accounts receivable	81	%	63	%

	Three months ended March 31,
Big 3 Wholesalers combined:	2015		2014
Percentage of gross sales	76	%	62	%
Percentage of net sales revenues	67	%	45	%

	March 31, 2015		December 31, 2014
Percentage of gross trade accounts receivable	84	%	85	%

	Three months ended June 30,				Six months ended June 30,
Big 3 Wholesalers combined:	2015		2014 (as Restated)		2015		2014 (as Restated)
Percentage of gross sales	82	%	69	%	79	%	67	%
Percentage of net sales revenues	74	%	49	%	70	%	47	%

	June 30, 2015		December 31, 2014 (as Restated)
Percentage of gross trade accounts receivable	77	%	85	%

	Three months ended September 30,				Nine months ended September 30,
Big 3 Wholesalers combined:	2015		2014 (as Restated)		2015		2014 (as Restated)
Percentage of gross sales	76	%	79	%	78	%	73	%
Percentage of net sales revenues	66	%	43	%	69	%	46	%
	September 30, 2015		December 31, 2014 (as Restated)
Percentage of gross trade accounts receivable	78	%	85	%

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

The following table sets forth information about the Company’s income tax provision for the periods indicated (dollar amounts in thousands):

	Three Months ended March 31,
	2014 (as Restated)			2013
Income from continuing operations before income taxes	$	17,595		$	16,257
Income tax provision	8,101			5,415
Net income from continuing operations	$	9,494		$	10,842
Income tax provision as a percentage of income before income taxes	46.0		%	33.3		%

The following table sets forth information about the Company’s income tax provision for the periods indicated (dollar amounts in thousands):

	Three Months ended June 30,						Six Months ended June 30,
	2014 (as Restated)			2013			2014 (as Restated)			2013
Income (loss) from continuing operations before income taxes	$	(1,251	)	$	19,982		$	16,344		$	36,239
Income tax provision (benefit)	(499		)	7,345			7,602			12,760
Net income (loss) from continuing operations	$	(752	)	$	12,637		$	8,742		$	23,479
Income tax provision (benefit) as a percentage of income (loss) before income taxes	(39.9		)%	36.8		%	46.5		%	35.2		%

The following table sets forth information about the Company’s income tax provision for the periods indicated (dollar amounts in thousands):

	Three Months ended September 30,						Nine Months ended September 30,
	2014 (as Restated)			2013			2014 (as Restated)			2013
Income (loss) from continuing operations before income taxes	$	(24,247	)	$	19,982		$	(7,903	)	$	56,221
Income tax provision (benefit)	(11,914		)	7,777			(4,312		)	20,537
Net income (loss) from continuing operations	$	(12,333	)	$	12,205		$	(3,591	)	$	35,684
Income tax provision (benefit) as a percentage of income before income taxes	(49.1		)%	38.9		%	(54.6		)%	36.5		%

The following table sets forth information about the Company’s income tax provision for the periods indicated (dollar amounts in thousands):

	Three Months ended March 31,
	2015			2014
Income from continuing operations before income taxes	$	58,328		$	17,595
Income tax provision	20,790			8,101
Net income from continuing operations	$	37,538		$	9,494
Income tax provision as a percentage of income before income taxes	35.6		%	46.0		%

The following table sets forth information about the Company’s income tax provision for the periods indicated (dollar amounts in thousands):

	Three Months ended June 30,						Six Months ended June 30,
	2015			2014 (as Restated)			2015			2014 (as Restated)
Income (loss) from continuing operations before income taxes	$	50,358		$	(1,251	)	$	108,686		$	16,344
Income tax provision (benefit)	17,850			(499		)	38,640			7,602
Net income (loss) from continuing operations	$	32,508		$	(752	)	$	70,046		$	8,742
Income tax provision (benefit) as a percentage of income (loss) before income taxes	35.4		%	(39.9		)%	35.6		%	46.5		%

The following table sets forth information about the Company’s income tax provision for the periods indicated (dollar amounts in thousands):

	Three Months ended September 30,						Nine Months ended September 30,
	2015			2014 (as Restated)			2015			2014 (as Restated)
Income (loss) from continuing operations before income taxes	$	74,015		$	(24,247	)	$	182,701		$	(7,903	)
Income tax provision (benefit)	26,048			(11,914		)	64,688			(4,312		)
Net income (loss) from continuing operations	$	47,967		$	(12,333	)	$	118,013		$	(3,591	)
Income tax provision (benefit) as a percentage of income (loss) before income taxes	35.2		%	(49.1		)%	35.4		%	(54.6		)%

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Selected financial information by reportable segment is presented below (in thousands). The Company has recasted prior periods such as the three month periods ended March 31, 2014 and 2013, to reflect the new segment reporting.

	Three Months Ended March 31,
	2014			2013
Revenues:
Prescription Pharmaceuticals	$	81,848		$	65,146
Consumer Health	8,774			8,708
Total revenues	90,622			73,854
Gross Profit:
Prescription Pharmaceuticals	45,284			34,023
Consumer Health	4,372			5,122
Total gross profit	49,656			39,145
Operating expenses	26,216			20,556
Operating income	23,440			18,589
Other expense	(5,845		)	(2,332		)
Income from continuing operations before income taxes	$	17,595		$	16,257

Selected financial information by reportable segment is presented below (in thousands). The Company has recasted prior periods such as the three and six month periods ended June 30, 2013, to reflect the new segment reporting.

	Three Months Ended June 30,						Six Months Ended June 30,
	2014 (as Restated)			2013			2014 (as Restated)			2013
Revenues:
Prescription Pharmaceuticals	$	119,481		$	67,362		$	201,327		$	132,508
Consumer Health	14,391			9,650			23,167			18,358
Total revenues	133,872			77,012			224,494			150,866
Gross Profit:
Prescription Pharmaceuticals	52,335			36,743			97,619			70,766
Consumer Health	8,536			5,349			12,908			10,471
Total gross profit	60,871			42,092			110,527			81,237
Operating expenses	60,135			19,841			86,351			40,397
Operating income	736			22,251			24,176			40,840
Other expense	(1,987		)	(2,269		)	(7,832		)	(4,601		)
Income (loss) from continuing operations before income taxes	$	(1,251	)	$	19,982		$	16,344		$	36,239

Selected financial information by reportable segment is presented below (in thousands). The Company has recasted prior periods such as the three and nine month periods ended September 30, 2013, to reflect the new segment reporting.

	Three Months Ended September 30,						Nine Months Ended September 30,
	2014 (as Restated)			2013			2014 (as Restated)			2013
Revenues:
Prescription Pharmaceuticals	$	114,953		$	72,677		$	316,280		$	205,185
Consumer Health	12,745			9,215			35,912			27,573
Total revenues	127,698			81,892			352,192			232,758
Gross Profit:
Prescription Pharmaceuticals	39,246			38,372			136,865			109,138
Consumer Health	6,254			5,325			19,162			15,796
Total gross profit	45,500			43,697			156,027			124,934
Operating expenses	57,530			21,509			143,881			61,906
Operating income (loss)	(12,030		)	22,188			12,146			63,028
Other (expense)	(12,217		)	(2,206		)	(20,049		)	(6,807		)
Income (loss) from continuing operations before income taxes	$	(24,247	)	$	19,982		$	(7,903	)	$	56,221

Selected financial information by reportable segment is presented below (in thousands). The Company has recasted prior periods such as the three month periods ended March 31, 2014, to reflect the new segment reporting.

	Three Months Ended March 31,
	2015			2014
Revenues:
Prescription Pharmaceuticals	$	210,554		$	81,848
Consumer Health	16,824			8,774
Total revenues	227,378			90,622
Gross Profit:
Prescription Pharmaceuticals	121,159			45,284
Consumer Health	9,004			4,372
Total gross profit	130,163			49,656
Operating expenses	56,896			26,216
Operating income	73,267			23,440
Other (expense)	(14,939		)	(5,845		)
Income from continuing operations before income taxes	$	58,328		$	17,595

Selected financial information by reportable segment is presented below (in thousands). The Company has recasted prior periods such as the three month periods ended March 31, 2014 included in the six months ended June 30, 2014, to reflect the new segment reporting.

	Three Months Ended June 30,						Six Months Ended June 30,
	2015			2014 (as Restated)			2015			2014 (as Restated)
Revenues:
Prescription Pharmaceuticals	$	206,062		$	119,481		$	416,616		$	201,327
Consumer Health	14,858			14,391			31,682			23,167
Total revenues	220,920			133,872			448,298			224,494
Gross Profit:
Prescription Pharmaceuticals	120,929			52,335			242,088			97,619
Consumer Health	7,478			8,536			16,482			12,908
Total gross profit	128,407			60,871			258,570			110,527
Operating expenses	62,305			60,135			119,201			86,351
Operating income	66,102			736			139,369			24,176
Other (expense)	(15,744		)	(1,987		)	(30,683		)	(7,832		)
Income (loss) from continuing operations before income taxes	$	50,358		$	(1,251	)	$	108,686		$	16,344

Selected financial information by reportable segment is presented below (in thousands). The Company has recasted prior periods such as the three month periods ended March 31, 2014 included in the nine months ended September 30, 2014, to reflect the new segment reporting.

	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014 (as Restated)			2015			2014 (as Restated)
Revenues:
Prescription Pharmaceuticals	$	240,995		$	114,953		$	657,611		$	316,280
Consumer Health	15,806			12,745			47,488			35,912
Total revenues	256,801			127,698			705,099			352,192
Gross Profit:
Prescription Pharmaceuticals	155,242			39,246			397,330			136,865
Consumer Health	7,770			6,254			24,252			19,162
Total gross profit	163,012			45,500			421,582			156,027
Operating expenses	72,245			57,530			191,446			143,881
Operating income (loss)	90,767			(12,030		)	230,136			12,146
Other (expense)	(16,752		)	(12,217		)	(47,435		)	(20,049		)
Income (loss) from continuing operations before income taxes	$	74,015		$	(24,247	)	$	182,701		$	(7,903	)